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INTRODUCTION 
 
The term asbestos is a commercial term rather than a true mineralogic definition 
[1] and refers to a group of naturally occurring mineral fibers, basically divided into two 
subgroups: the serpentine subgroup and the amphiboles subgroup. 
To the serpentine subgroup belongs only the chrysotile (white asbestos), a 
hydrated magnesium silicate with a wavy and filamentous morphology of its elementary 
bundles, a marked tendency for its elementary bundles to split into single and shorter 
fibrils and a Mg3Si2O5OH4 chemical formula. 
The amphiboles subgroup is composed by the varieties crocidolite (blue asbestos, 
with a Na2Fe3
++
Fe2
+++
Si8O22OH2 chemical formula), amosite (brown asbestos, with a 
Fe-Mg7Si8O22OH2 chemical formula), tremolite (chemical formula Ca2Mg5Si8O22OH2), 
actinolite (chemical formula Ca2MgFe5Si8O22OH2) and anthophyllite (chemical formula 
Mg-Fe7Si8O22OH2). All the amphiboles share a typical straight morphology with 
parallel sides and do not show nor splayed ends neither a marked longitudinal splitting 
tendency. Crocidolite and amosite varieties are referred together as the Commercial 
Amphiboles, while tremolite, actinolite and anthophyllite represent the Non-
Commercial Amphibole series. 
Asbestos deposits occur in four types of rocks (alpine-type ultramafic rocks, 
stratiform ultramafic intrusions, serpentine limestone and banded ironstones) showing a 
well-defined geographic distribution: chrysotile deposits locate mainly in Quebec, 
Rhodesia, Russia, China, Italy and USA; crocidolite deposits in South Africa, Australia, 
Colombia and Rhodesia; amosite and actinolite deposits in South Africa and India; 
tremolite deposits in the Mediterranean region, Pakistan and South Korea; anthophyllite 
deposits in Finland and USA [2]. 
Because of its extraordinary chemical and physical properties, asbestos has been 
very intensively exploited in either the pre-industrial and the industrial age. In modern 
times the first attempts at serial asbestos mining were done in the Urali region from 
1720, in Quebec from 1886 and in South Africa from 1910. In Italy the industrial 
asbestos mining started in the Valtellina district in 1866 and in the small town of 
Balangero -near Turin- in 1923 [3]. Chrysotile, crocidolite and amosite are the true 
commercial varieties of asbestos (chrysotile alone representing worldwide the 90-95% 
fraction of the commercial asbestos [4,5]), mainly consumed in textile industry, 
construction industry, shipyard activities, insulation activities and friction materials 
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industry. World production of asbestos peaked in 1975 at about 5.09 million metric tons 
and then decreased (about 4 million metric tons in 1990 and less than 2 million metric 
tons in 2000) [6] mainly because of the supervening legislative bans rather than the 
technical abandon of the mineral. In Italy the crocidolite ban took place in 1986, while 
the definitive ban on all the asbestos varieties was imposed in 1992. 
National and international bans on asbestos were introduced because of the 
cumulative evidences about the relevant asbestos pathogenicity for humans: in 1890 the 
inhalation of asbestos fibers was first related to the development of a non-specific lung 
disease, while in 1907 some human deaths were positively linked to asbestos exposure 
[7]; in 1924 W.E. Cooke described an asbestos-related lung fibrosis and named it 
asbestosis [8]; in the Thirties and Forties the first reports about lung cancer in asbestos 
workers were published [9,10] and the hypothesis about the asbestos carcinogenicity for 
exposed workers began to circulate [11]; in 1960 Wagner at al reported several cases of 
malignant mesothelioma among asbestos miners from South Africa [12]. 
Asbestos fibers are nowadays considered an etiologic factor for pleural plaques 
and other benign pleural diseases, asbestosis, malignant mesothelioma and lung cancer 
in all its 4 major subtypes [7,13-18]. At the present time conflicting opinions do exist 
about the etiologic role of asbestos fibers for other neoplastic diseases such as the 
gastrointestinal cancer, pancreatic cancer, renal cell cancer, laryngeal cancer, ovarian 
cancer and leukemia/lymphoma [19]. Asbestos-related diseases show a long latency 
period (mean interval of 30-40 years for mesothelioma [20-22]) and asbestos-induced 
neoplastic diseases are therefore still increasing despite the introduced bans: asbestos 
pathology and asbestos clinical medicine are thus still actual topics. The latency 
between occupational asbestos exposure and the diagnosis of asbestos-related cancer 
also explains the actual focus on asbestos by the law courts and consequently by the 
forensic pathology [23,24]. 
After the asbestos ban the pattern of asbestos exposures was expected to gradually 
change with a predominant shift from the typical massive occupational and 
paraoccupational exposures (the first and the second waves of asbestos exposure) to the 
milder environmental exposures both from antropic and natural sources (the third wave 
of asbestos exposure) [6]. 
   
The current guidelines for the clinical and pathological diagnosis of asbestos-
related diseases were stated in January 1997 in the Helsinki Document [25]. The 
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Helsinki Document first underlined that lung analyses for asbestos fibers can provide 
data to supplement and integrate the occupational history data and then stated that an 
Electron Microscope amphibole fibers count over 1,000,000/g dry (fibers > 1 μm in 
length) or an Electron Microscope long amphibole fibers count over 100,000/g dry 
(fibers > 5 μm in length) or an Asbestos Bodies count over 1,000/g dry or an Asbestos 
Bodies count over 1/ml of bronchoalveolar lavage fluid identify persons with a high 
probability of exposure to asbestos dust at work. Focusing on mesothelioma, the 
Helsinki Document briefly reminded that non all mesotheliomas are asbestos-induced 
cancers and stated that such a cancer can be related on a probability basis to asbestos 
exposure in the presence of a lung fiber count clearly exceeding the reference values of 
that laboratory or in the presence of a reliable history of asbestos exposure. Focusing 
later on lung cancer, the Helsinki Document stated that a 2-fold risk of lung cancer is 
related to an amphibole fibers load over 5,000,000/g dry of lung tissue (fibers > 1 μm in 
length) or to a long amphibole fibers load over 2,000,000/g dry of lung tissue (fibers > 5 
μm in length) or to an Asbestos Bodies count equal to 5,000-15,000/g dry or to an 
Asbestos Bodies count equal to 5-15/ml of bronchoalveolar lavage fluid. 
Helsinki statements about the asbestos ascription of lung cancers have been 
vigorously debated [26-31] and opposite to the articulated Helsinki Criteria stands the 
hypothesis of asbestos-induced lung onchogenesis only in the presence of an asbestosis 
background. According to the concept that an asbestos-related disease (and especially 
an asbestos-related cancer) cannot be automatically labelled as an occupational disease, 
the Helsinki Document also recommended in its introductive section that each 
laboratory should establish its own reference values from the general population and 
that the median values for occupationally exposed populations should be substantially 
above the reference values. 
In 1998 the European Respiratory Society Task Force further developed some 
Helsinki issues and published the guidelines for the mineral fiber analyses in biological 
samples [32]. According to the European Respiratory Society guidelines, each 
laboratory should create its reference values for lung burden of mineral fibers by 
sampling up to five different subgroups from the general population: the subgroup A 
composed by individuals from rural areas with no identifiable occupational exposure to 
asbestos; the subgroup B composed by individuals from urban areas with no identifiable 
occupational exposure to asbestos; the subgroup C composed by individuals from areas 
with asbestos deposits in the soil; the subgroup D composed by individual with 
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identifiable non-occupational exposure to asbestos; the subgroup E composed by 
individual with identifiable occupational exposure to asbestos. Surgical or necroscopic 
samples are needed to properly analyze such subgroups from the general population. 
Surgical series and necroscopic series show different advantages and suffer different 
limitations: surgical series offer small amount of lung tissue but allow the researchers to 
establish a thorough occupational history for every single case, while necroscopic 
sample series offer great amount of lung tissue but do not allow the researchers to 
establish a thorough occupational history for every single case. For necroscopic series 
lacking occupational histories assessment, it is recommended by the European 
Respiratory Society guidelines a preliminary exclusion of cases with clinical or 
pathological diagnosis of diseases possibly related to asbestos exposure. 
The reference values used by the 6 laboratories participating the European 
Respiratory Society Asbestos Task Force for urban individuals without known 
occupational exposure to asbestos (subgroup B) are about 1,000,000-4,000,000 ff/g dry 
of lung tissue for total fibers and about 150,000-300,000 ff/g dry of lung tissue for long 
fibers (fibers > 5 μm in length). 
 
The lung content of both coated and uncoated asbestos fibers is a widely accepted 
index of the lifetime cumulative exposure to asbestos [33-38]. Human exposure to 
asbestos mainly happen through the inhalation of single fibers or fiber bundles and the 
asbestos lung burden is to be considered as the result from the dynamic balance between 
the fibers deposition (the fibers access to the deep lung being crucially affected by the 
respiratory function and the pulmonary anatomy of the subject) and the fibers clearance 
(the fibers egress from the deep lung being crucially affected by the alveolar 
macrophage function and the lymphatic drainage to the pleural space and the main 
lymphatic circulation) [14,39]. Also the morphological and chemical features of the 
airborne fibers crucially affect their deposition to clearance rate within the lower 
airways and the deep lung. Chrysotile bundles regularly stop in the upper airways 
[40,41] while single chrysotile fibers accessed to the alveolar zones rapidly tend to leach 
magnesium and to split into small fibrils: chrysotile consequently shows a low 
biopersistence compared to amphiboles [42-44] and the estimation of the lung burden of 
asbestos fibers is therefore a better index for amphibole exposition then for asbestos 
exposition as a whole [45]. Chrysotile has a pulmonary half-life of months, while 
amphiboles can remain in the lung parenchyma for decades [14,46-48]. However some 
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authors suggest that two different sets of inhaling chrysotile fibers do exist, the former 
being represented by smaller and easy-clearing fibers (fibers cleared within weeks or 
months very unlikely to be detected by lung burden estimations) and the latter being 
represented by longer fibers prone to penetrate the thin alveolar walls and to fix 
perpetually in the subepithelial interstitium of the lung (“harsh” fibers more likely to be 
detected by lung burden estimations) [49,50]. It seems however that for chrysotile fibers 
a lower persistence inside the lung parenchyma combines with a higher persistence 
around the black spots in the pleural space [51]. 
Smoking is considered to inhibit asbestos clearance from the lung parenchyma 
[52,53].   
Coated asbestos fibers (also called Asbestos Bodies, AB) form in the deep lung 
when a mixed layer of iron-protein-mucopolysaccharide material covers a single 
resident asbestos fiber [54-57]. Coated fibers usually represent a small fraction of the 
total asbestos content within the lungs at a single point in time [58-61] and the precise 
amount of this fraction depends on either host-dependent and host-independent 
variables [62]. Among the host-independent variables the most important seem to be the 
fiber dimensions (thick fibers longer than 10-20 μm more likely to be coated [58,63]), 
the fiber surface features (smooth fibers less likely to be coated [64]) and the fiber 
chemical composition (amphibole fibers more likely to be coated than chrysotile fibers 
[56,65-72]), while among the host-dependent variables the most relevant is the genetic 
susceptibility to be a poor AB-former versus a rich AB-former [67,73]. The lung AB 
burden (the product of a suggested balance between AB formation and AB breakdown  
[74,75]) is then to be considered as a ultra-mediated index of the lifetime cumulative 
exposure to asbestos [76], two identically exposed individuals turning out to be very 
different in AB count just because of different genetic tendencies in forming AB. 
Especially in the case of a low AB count [77], an isolated AB estimation is therefore not 
reliable in analyzing the lifetime cumulative exposure of a patient and it needs to be 
followed by the estimation of the burden of uncoated asbestos fibers [76,78]. Moreover 
the Asbestos Bodies belong to the wide group of Ferruginous Bodies (FB group 
comprehensive of true AB and bodies other than AB) and the estimation of the AB 
content of the lungs is usually performed using the traditional light microscope: this 
inexpensive but barely morphological technique shows very well all the FB in the lung 
digest but does not allow the analyst to make a definite chemical distinction between 
true AB and other bodies [79,80]. Nonasbestos FB may form -with limited peculiar 
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morphology- on talc fibers, sheet silicates (up to 20% of the total FB burden in some 
series from the general population) [66], carbon fibers [81,82] (up to 90% of the total 
FB burden in series from the general population [56]), metal oxides (mainly titanium 
bodies [83]), ManMade Mineral Fibers [84-86], diatomaceous earth [66,82] and erionite 
fibers [87]. 
 
Asbestos fibers quantification in lung tissue is typically performed by light 
(coated fibers counting) or electronic (uncoated fibers counting) microscopy on lung 
digested samples [88]. Samples to be analyzed should be representative of the whole 
lungs and the preliminary samples selection should warrant a wide mapping of all the 
accessible tissue [89]: necroscopic samples (usually wide and bilateral) are therefore 
more informative than surgical samples (usually small and monolateral). Lung 
dissolution can be accomplished either by wet chemical digestion or low-temperature 
ashing. The wet chemical digestion is usually performed through the potassium 
hydroxide procedure or the sodium hypochlorite procedure [90]. Once the dissolution of 
the lung sample is complete, the inorganic residue may be vacuum-filtered and collected 
on 0.2-0.45 μm pore size polycarbonate membranes. The polycarbonate membrane can 
be then analyzed in Light Microscopy (traditional Light Microscopy or Contrast Phase 
Light Microscopy), Scanning Electron Microscopy or Transmission Electron 
Microscopy. AB counting can be reliably performed using LM at a magnification 100x-
400x and the results for an individual analysis can be reported as number of AB per 
gram of wet tissue or better as number of AB per gram of dry tissue. AB counting 
assays performed on case series should also record the fraction of cases featuring at 
least one AB in the LM analysis. SEM and TEM instruments should always be coupled 
with an EDXA system for the chemical characterization of all the detected fibers and 
their results should be reported as number of asbestos fibers (both coated and uncoated) 
per gram of dry tissue with specific estimations about chrysotile, Commercial 
Amphiboles and Non-Commercial amphiboles. SEM and TEM analysis should also 
quantificate the lung burden of non-asbestos fibers. For SEM and TEM analysis it is 
mandatory a preliminary statement about the so-called counting rules, with a special 
focus on the analytical sensitivity and on the dimensional parameters of the fibers to be 
considered and counted [89]. 
The microscopic estimation of the asbestos lung content allowed both the 
researchers and the clinicians to get a better comprehension about the asbestos 
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pathogenicity and to correlate the occurrence of various fiber-related lung diseases with 
the cumulative fiber burden within this target tissue [43,88,91,92]. Over the last decades 
many works have been published about the relationship between asbestosis occurrence 
and lung asbestos burden [93-97] (heavy lung asbestos burden in the vast majority of  
cases with median values well above the 1.000 AB/g dry cut off and the 1,000,000 ff/g 
dry cut off [89]), benign pleural diseases occurrence and lung asbestos burden [35, 98-
101] (patients with pleural plaques having considerably smaller asbestos burden than 
patients with asbestosis and slightly smaller burden than patients with mesothelioma 
[89]), mesothelioma occurrence and lung asbestos burden [35,93,97,102-105] (patients 
with mesothelioma having smaller asbestos burden than patients with asbestosis [89]; 
existence of a subgroup of mesothelioma patients with a mean asbestos content in lung 
tissue indistinguishable from a reference population [20,93,106-108]) and lung cancer 
occurrence and lung asbestos burden [93,94,104,109,110] (asbestos-related lung cancers 
showing histological asbestosis and/or an asbestos content in the lung very similar to 
patients with asbestosis [89]). Other works have rather investigated the correlation 
between some kinds of well-known occupational asbestos exposure and the lung 
asbestos burden [89]: asbestos insulators [111], asbestos manufacturers [112-114], 
shipyard workers [115] and power plants workers [116] show the greatest median 
burdens of asbestos in lung tissue with values well above the Helsinki cut offs for non-
trivial exposure; molten metal workers, construction workers [21], and chemical 
refinery workers [117,118] show asbestos median burdens smaller than the previous 
groups but nonetheless above the Helsinki cut offs for non-trivial exposure; railroad 
workers [115,119] and brake repair workers [120-123] show median burdens of lung 
asbestos greater than the general population and very close to the Helsinki cut offs for 
non-trivial exposure. An increased risk of developing asbestos-associated diseases has 
been reported among household contacts of asbestos workers too: the asbestos lung 
content from the relatives of asbestos workers (mainly workers from the first group 
identified above) is very similar to that of molten metal workers, construction workers 
and chemical refinery workers and it is then greater than that of the general population 
[89,124,125]. 
The determination of the asbestos lung burden from the general population is a 
crucial work in either an epidemiological and a clinical perspective. Such a background 
reference allows in fact the researchers to distinguish dose-dependent from dose-
independent asbestos-related diseases and to stratify dose-dependent asbestos-related 
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diseases and also allows the clinicians to properly investigate the etiology of any single 
disease hypothetically connected with asbestos exposure. Reference values from the 
general population are also very important for the forensic pathologists dealing with 
asbestos-related claims. Every laboratory involved in routine asbestos estimations 
should therefore define its reference evidences from the general population and should 
strictly compare to these evidences all the results coming from clinical or forensic 
routine analyses [25,32]. 
In Appendix 1 and 2 the results from main studies about AB lung counting and 
asbestos fibers lung counting in the general population are summarized. As detailed in 
the Appendixes, some of the  studies directly focused on general population analyses, 
while others used general populations as control populations versus main case-series 
having asbestos-related diseases or known occupational asbestos exposure. In the 
Appendixes only results referring to the general population are reported. 
 
STUDY AIMS 
 
The present work aims at describing the asbestos lung burden in a sample of the 
general population constituted by subjects resident in the city of Milan. The study 
sample includes a necroscopic series selected from the 2009-2011 routine practice at the 
Institute of Forensic Medicine of Milan. 
The performed asbestos burden investigation was both qualitative and 
quantitative. 
We examined both the Asbestos Bodies lung prevalence and the asbestos fibers 
lung burden from the selected sample and we analyzed the influence by age, gender, 
residential district, birthplace and smoking habit. We focused on asbestos fibers type 
and metrics and we were also able to evaluate other inorganic fibers lung burden .  
As stated in the 1998 Report from the European Respiratory Society Asbestos 
Task Force, the creation of reliable reference values is a multistep task and studies on 
necroscopic series represent just one of the pivotal steps: the present work dealt with a 
55-cases wide necroscopic populations according to the European Respiratory Society 
recommendations for the subgroup 2B (individuals from urban areas with no 
identifiable occupational exposure). 
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MATERIALS AND METHODS 
 
In the period running from January 2009 to August 2011 55 cases were selected 
from the necropsy routine at the Institute of Forensic Medicine of Milan-Italy. 
The experimental population was composed by 30 males (10 cases ≤ 30 years old, 
10 cases > 30 and ≤ 60 years old and 10 cases > 60 years old) and 25 females (5 cases ≤ 
30 years old, 11 cases > 30 and ≤ 60 years old and 9 cases > 60 years old). 
Criteria for the cases to be enrolled in the experimental population were the 
caucasoid race, the stable residence in Milan-Italy and the exitus from an endogenous 
pathology or from a major blunt trauma. Such inclusion criteria were established after 
an epidemiological survey of the 2006-2008 routine necroscopic practice at the Institute 
of Forensic Medicine of Milan. The only exclusion criterion was the occurrence of ante-
mortem or post-mortem diagnosis of any of the asbestos-related pathologies (pleural 
adhesions, lung fibrosis, pleural plaques, pleural and peritoneal mesothelioma, lung 
cancer). 
Some anamnestic notes about global health status, tobacco smoking habit (non-
smoker versus previous smoker versus current smoker class I: 1-10 cigarettes/die, class 
II: 10-20 cigarettes/die or class III: > 20 cigarettes/die) and ante-mortem job 
occupations were obtained for every case through a brief interview and/or a phone call 
with the relatives of the selected subject. A subject was considered to be a former 
smoker after at least a 6 months period of complete ante mortem smoking abstinence. 
For every case in the population was also preliminarily recorded its exact Milan-
residence address. For the purpose of the present study, the Milan topography was 
considered to be composed by four main sectors: the North West (zone 7 + zone 8), the 
North East (zone 2 + zone 3 + zone 9), the City Centre (zone 1) and the South (zone 4 + 
zone 5 + zone 6). 
Every case underwent a complete judicial autopsy and every necroscopic 
procedure comprised a standardized pulmonary sampling allowing a wide lungs 
mapping [32,78]: five samples free from macroscopic abnormalities were cumulatively 
obtained from both the lungs, one 10 g subpleural sample coming from each pulmonary 
lobe. In agreement with the traditional lung mapping for forensic pathology, the upper 
lobe samples were obtained from the apical region while the lower lobe samples were 
obtained from the dependent region. 
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The lung samples from the same case were pooled together [72,78], half the 
pooling being 10%-formalin fixed and half the pooling getting a temporary 2-3 °C 
refrigeration. The samples undergone the 2-3 °C refrigeration step were subsequently 
prepared for the Ferruginous Bodies counting (counting to be performed by traditional 
Light Microscopy), while the samples undergone the 10%-formalin fixation procedure 
were subsequently prepared for the asbestos fibers analysis (analysis to be performed by 
Scanning Electron Microscopy). 
 
Methods employed for the Ferruginous Bodies (FB) analysis 
 
The samples to be analyzed for the FB counting were prepared according to a 
simplified version of the wet digestion technique described by Mitha and Pooley in 
1993 [126]: 1 g of wet lung composed by 5 discrete samples (each sample coming from 
a different lobe and each weighing about 0.20 g [127]) was chemically digested in a 20 
ml solution of commercial bleach until no macroscopic residue was detectable anymore. 
The sodium hypochlorite digestion step usually needed 24-48 hours to be complete. 
After the sodium hypochlorite digestion was completed, 5 ml of a 30% hydrogen 
peroxide solution were added to the original solution for a time of 4-6 hours. 
The whole digestion procedure was accomplished in a disposable plastic vial at a 
constant ambient temperature of 20-22 °C and did not feature any centrifugation or 
shaking manoeuvre. The Authors decided to avoid heating or shaking on the digesting 
solution to minimize the risk about artificial FB breakdown [128,129]. After the two-
steps lung digestion was completed, the whole solution was vacuum-filtered through a 
0.2 µm pore size polycarbonate Millipore® membrane. After sufficient drying, the 
unstained membrane was directly mounted on a typical histological slide with coverslip 
and it was then completely explored at both the 100x and the 400x magnifications in 
bright field LM. The LM analysis was collegially performed by two distinct 
professional pathologists (one forensic pathologist and one pathologist with a 35-years 
experience in pulmonary pathology) and all the cases showing one or more FB 
underwent a further independent LM test by an experienced FB analyst [130]. After the 
independent confirmation by the experienced FB analysis, only the morphologically 
typical Asbestos Bodies (AB) were counted. AB counting results were first reported as 
number of AB/wet lung gram [131,132], but every case with a positive AB count had a 
further laboratory procedure (1 g of wet lung composed by pieces of tissue adjacent to 
the original five 0.20 g digested samples was dried to constant weight at 60 °C [133]) to 
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calculate its own lung wet to dry weight ratio and then to allow AB estimations also as 
AB/dry lung gram [32,134,135]. All the cases with a positive AB counting showed a 
wet to dry ratio very close to 10, thus allowing a simple multiplicative conversion from 
the AB/g wet count to the AB/g dry count. 
The LM analysts had no knowledge about SEM analyses results or about the 
intrinsic variables of each testing case. The experienced LM analyst was generally 
asked to check some filters for morphologically typical AB. 
With the notable exception of the confirmation LM test on cases having a FB 
count ≥ 1, the whole technical and analytical procedure for the AB counting was 
performed at the Institute of Forensic Medicine of Milan. 
The whole technical procedure was performed in strict agreement with the routine 
forensic laboratory guidelines against artificial contamination of human samples [78].   
 
Methods employed for the asbestos fibers analysis 
 
According to the method [136,137] described by Wang et al in 2000, the formalin-
fixed pool composed by five lung samples was sequentially put for 24 hours in a 
bidistilled-water bath to remove the formalin matrix and then freeze dried [138]. 50 mg 
of the freeze-dried sample underwent a complete decomposition through a Emitech® 
K1050X low-temperature oxygen-plasma asher [139] (15 hours of 100 W and 0.06 
mbar ashing) and the ashes were sequentially suspended in a solution of 20 ml distilled-
water, 20 ml isopropyl alcohol and 20 ml hexane, vigorously shaken for a few minutes 
and vacuum-filtered on a 0.2 µm pore size polycarbonate Millipore® membrane. After 
filtering and drying, the polycarbonate membrane collecting the residue was completely 
decomposed by a second low-temperature oxygen-plasma ashing (15 hours of 100 W 
[140] and 0.06 mbar ashing) and the ashes were suspended in 50 ml of 3% distilled-
water solution of ethylic alcohol. A 10 ml and a 20 ml sample from that solution were 
finally vacuum-filtered on two distinct 0.2 µm pore size polycarbonate Millipore® 
membranes, thus producing a “light” membrane and a “heavy” membrane for the SEM 
analysis (the selection for the best membrane to analyze was later performed by the 
SEM analyst during a preliminary few fields SEM analysis).  
A 5 mm
2 
section of both the polycarbonate membranes underwent a gold-coating 
procedure. 
After the preliminary SEM selection of either the light or the heavy membrane, 
each case from the population got a 12000x SEM analysis on a gold-coated 5 mm
2 
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section of the selected filter. All the fibers (coated and uncoated asbestos fibers + non-
asbestos fibers) longer than 1 µm and with an aspect ratio ≥ 3:1 were counted, the fiber 
completely locating inside the tested microscopic field counting as 1 and the fiber just 
partially locating inside the tested microscopic field counting as ½. The SEM analysis 
stopped after the positive counting of 30 asbestos fibers or after the accomplished test of 
a number of microscopic fields sufficient to warrant a detection limit at about 300.000 
fibers/g dry (200-250 fields in cases not showing any asbestos fibers). The SEM 
identification of a true fiber (a corpuscle with two straight parallel sides and an aspect 
ratio ≥ 3 : 1) was mainly morphological, while the distinction between asbestos and 
non-asbestos fibers was either morphological and chemical. The chemical composition 
of every encountered fiber was investigated by the Energy Dispersive X-rays Analysis-
system [141] connected with the SEM. The encountered fibers were alternatively 
grouped as asbestos fibers (further divided into chrysotile, Commercial Amphiboles -
amosite and crocidolite- and NonCommercial Amphiboles -tremolite, anthophyllite and 
actinolite-), talcum fibers, titanium-containing fibers and inorganic fibers other than 
asbestos. No attempt was made to differentiate true asbestos fibers from cleavage 
fragments. With very few exceptions, every encountered asbestos fiber was measured 
for length and width. 
The counting results were expressed as number of fibers per g of dry tissue (ff/g 
dry) together with the 95% Confidence Interval (95% CI) and the Detection Limit (DL) 
values. The DL was defined case by case as the upper boundary of the 95% Poisson CI 
for a SEM zero count. The cases not showing any asbestos fiber in the SEM analysis 
were then best defined as having an asbestos-fibers concentration lower than the half of 
the analytical sensibility (AS). This value was calculating as 1/2 x AS = 1/6 x DL, 1/6 
being the multiplicative factor for the minimal hypothesis of just a half fiber in the SEM 
count. For the successive median values calculations, the cases having a SEM count 
lower than the 1/2 x AS value were considered as having a SEM count equal to the 1/2 x 
AS value itself [62]. 
All the SEM analyses were performed by the same experienced analyst. The SEM 
analyst had no knowledge about the LM analyses results or about the intrinsic variables 
of each testing case.  
The whole technical and analytical procedure for asbestos fibers count was 
performed at the ARPA Lombardy Laboratories in Milan. ARPA Milan Laboratories 
represent the official Regional Centre for asbestos fibers analysis from both atmospheric 
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and human samples and regularly cooperate with the Mesothelioma Registers from the 
northern Italian regions [142,143]. 
 
Statistical analyses 
 
Standard descriptive statistics (means, Standard Deviations [SDs], medians, 
Interquartile-Ranges [IQRs], and proportions) have been used to summarize data. For 
normally distributed data, Student’s t-test and Fisher’s exact test were used to 
investigate potential differences in the variable distributions. Global and type-specific 
fiber burden showed asymmetric distribution and were log-transformed to approximate 
normality. Consistently, differences in the fiber burden distribution among strata of 
categorical variables of interest were investigated using nonparametric tests (Wilcoxon-
Mann-Whitney Test and Kruskal-Wallis Test). 
The association between fiber burden and age at death was also evaluated with 
linear models by regressing the log-transformed fiber burden variable over age at death. 
Effects are therefore expressed as percent change in fiber burden per 1-year increase in 
age at death. 
For fiber length and diameter geometric means and corresponding 95% 
Confidence Intervals (95% CIs) were reported. Differences in fiber dimensions across 
fiber types were evaluated using one-way ANOVA. All tests of statistical significance 
were two sided. Statistical analyses were performed using Stata/MP 11.1 (Stata 
Corporation, College Station, TX). 
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RESULTS 
 
The experimental population was composed by 55 cases, 30 males and 25 
females. The mean age from the whole experimental population was 44,9 ± 20,4 years 
(range 18-83 years). In great detail, 15 cases (10 males and 5 females) belonged to the ≤ 
30 years old class, 21 cases (10 males and 11 females) to the 30-60 years old class and 
19 cases (10 males and 9 females) to the > 60 years old class. 
The mean age did not significantly differ between genders (42,5 ± 20,6 years for 
males; 48 ± 20,2 years for females). 
All the cases were residents in Milan: 19 cases lived in the Southern zone, 15 
cases in the North Eastern zone, 14 cases in the North Western zone and 7 cases in the 
City Centre. Twenty-six cases from the whole population were born in Milan (mean age 
40,7 ± 18,7 years), while 29 cases were not (mean age 49 ± 21,1 years). 4 out of the 29 
cases born outside Milan were born abroad. According to the tobacco smoking habit, 
the cases from the experimental population were alternatively divided into the non-
smokers subgroup and the smokers subgroup. Reliable notations about the smoking 
habits were not available in 6 cases. 19 subjects were never smokers and 4 were former 
smokers. The smokers subgroup was composed by 26 cases and was further divided 
into the 1
st
 smoking class (6 cases usually smoking less than 10 cigarettes/die), the 2
nd
  
smoking class (6 cases usually smoking 11-20 cigarettes/die) and the 3
rd
 smoking class 
(14 cases usually smoking more than 20 cigarettes/die). 
Table 1 reports the general features of each study subject, whereas in Table 2 the 
results of the microscopic analyses (Light Microscope and Scanning Electron 
Microscope analyses) performed are illustrated. 
 
Morphologically typical Asbestos Bodies were found in the 14.5% of cases (8 
cases). The Asbestos Bodies prevalence was 0% in the ≤ 30 years old subgroup, 9.5% in 
the 30-60 years old subgroup and 31.6% in the > 60 years old subgroup (p = 0,034). For 
the positive cases, the range of the AB counting was 10-110 AB/g dry. In all the AB 
positive cases, the SEM-tested asbestos burden was higher than the analytical 
sensibility. For such cases the SEM asbestos burden range was 60,000-2,000,000 ff/g 
dry, the case with the lowest SEM count (60,000 ff/g dry) being unexpectedly the one 
with the greatest LM AB count (110 AB/g dry). For 2 cases testing positive for 
Asbestos Bodies chrysotile was the only asbestos variant detected in the SEM analysis. 
17 
 
        Table 1: main features of each study subject. 
 Sex Age 
Residence 
(Milan) 
Birthplace Work 
Tobacco smoke 
(cigarette/die) 
Case 
1 
F 42 NW Milan, Italy Housewife NS 
Case 
2 
M 78 NW Teramo, Italy Retired (career soldier) 10-20 
Case 
3 
M 74 S Milan, Italy 
Retired (automotive 
industry worker) 
> 20 
Case 
4 
M 69 C Catania, Italy Retired FS 
Case 
5 
M 49 NE Milan, Italy Computer engineer NA 
Case 
6 
M 72 NE 
Syracuse, 
Italy 
Retired 
(clerical worker) 
> 20 
Case 
7 
F 68 NE Palermo, Italy Retired (housewife) NS 
Case 
8 
M 23 NE Milan, Italy Train guard 10-20 
Case 
9 
F 64 NE Lecco, Italy Secretary > 20 
Case 
10 
M 18 S Romania Barman NS 
Case 
11 
M 34 NE Milan, Italy Long term unemployed NS 
Case 
12 
M 51 S Foggia, Italy Warehouse-keeper > 20 
Case 
13 
M 41 C Milan, Italy Clockmaker 1-10 
Case 
14 
F 38 NW Monza, Italy Make-up artist 10-20 
Case 
15 
M 43 S Milan, Italy 
Unemployed 
(concierge) 
> 20 
Case 
16 
M 59 NW 
Mantova, 
Italy 
Retired 
(businessman in catering 
industry) 
> 20 
Case 
17 
F 48 S Milan, Italy 
Housewife 
(graphic-designer) 
NS 
Case 
18 
F 27 S Milan, Italy Student NS 
Case 
19 
F 49 S Belluno, Italy Housewife > 20 
Case 
20 
M 68 S Milan, Italy 
Retired 
(clerical worker) 
NS 
Case 
21 
F 79 S Milan, Italy Retired 1-10 
Case 
22 
M 80 S 
Reggio 
Emilia, Italy 
Retired NA 
Case 
23 
F 22 S Milan, Italy Barman NS 
Case 
24 
M 27 NE Monza, Italy Blue collar 1-10 
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Table 1 cnt: main features of each study subject. 
 Sex Age 
Residence 
(Milan) 
Birthplace Work 
Tobacco smoke 
(cigarette/die) 
Case 
25 
F 30 S Catania, Italy Housewife > 20 
Case 
26 
F 80 S Genova, Italy Retired (housewife) FS 
Case 
27 
M 30 NW 
Catanzaro, 
Italy 
Financial analyst NS 
Case 
28 
F 51 C Salerno, Italy Secretary FS 
Case 
29 
M 71 NW Foggia, Italy 
Retired 
(clerical worker) 
10-20 
Case 
30 
M 48 S Milan, Italy Computer programmer 10-20 
Case 
31 
M 33 NE Milan, Italy 
Unemployed 
(clerical worker) 
> 20 
Case 
32 
F 81 S Turin, Italy Retired (housewife) NA 
Case 
33 
F 73 NW Bari, Italy Retired (housewife) NS 
Case 
34 
M 37 NE Milan, Italy Barman > 20 
Case 
35 
M 51 C Milan, Italy Medical doctor > 20 
Case 
36 
M 79 C Catania, Italy 
Retired (professional 
musician) 
NS 
Case 
37 
M 64 NW Pavia, Milan 
Retired 
(truck driver) 
1-10 
Case 
38 
M 64 S Milan, Italy Teacher NS 
Case 
39 
F 83 NE Milan, Italy Retired (shop-keeper) NA 
Case 
40 
F 68 NE Milan, Italy Retired (secretary) NS 
Case 
41 
M 28 NE Milan, Italy Long term unemployed > 20 
Case 
42 
M 27 NE Milan, Italy Waiter 10-20 
Case 
43 
F 80 NW Rome, Italy 
Retired 
(kindergarten teacher) 
NS 
Case 
44 
M 22 C France Student NS 
Case 
45 
F 53 NW Milan, Italy Press agent NA 
Case 
46 
F 38 NE Milan, Italy Long term unemployed NA 
Case 
47 
F 22 NW Kazakhstan Student > 20 
Case 
48 
F 49 C Genova, Italy Secretary FS 
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Table 1 cnt: main features of each study subject. 
 Sex Age 
Residence 
(Milan) 
Birthplace Work 
Tobacco smoke 
(cigarette/die) 
Case 
49 
M 21 NW Milan, Italy Cook NS 
Case 
50 
M 30 S Milan, Italy Barman NS 
Case 
51 
F 23 NW Romania 
Unemployed 
(shop-assistant) 
NA 
Case 
52 
F 55 S Bari, Italy Clerical worker > 20 
Case 
53 
M 21 NW Milan, Italy Clerical worker NS 
Case 
54 
F 35 S Naples, Italy Housewife NS 
Case 
55 
F 44 NE Naples, Italy Long term unemployed 1-10 
 
M = Male, F = Female. 
NE = North East, NW = North West, C = City Centre, S = South. 
NS = Non Smoker, FS = Former Smoker. 
NA = Not Available. 
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Table 2: main results of the LM and SEM analyses. 
 
AB 
(LM 
count) 
ASBESTOS FIBERS TALC FIBERS TITANIUM DIOXIDE OTHER FIBERS 
SEM burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
Fibers 
type 
SEM Burden 
(ff/g dry) 
95% CI 
(ff/g dry) 
SEM Burden 
(ff/g dry) 
95% CI 
(ff/g dry) 
SEM Burden 
(ff/g dry) 
95% CI (ff/g 
dry) 
Case 
1 
0 400,000 
120,000-
1,160,000 
CA 57% 
NCA 43% 
570,000 
180,000-
1,320,000 
< 1/2 AS  1,500,000 
780,000-
2,520,000 
Case 
2 
0 420,000 
40,000-
1,210,000 
Chr 60% 
NCA 40% 
< 1/2 AS  < 1/2 AS  4,500,000 
2,990,000-
6,600,000 
Case 
3 
10/g dry 1,200,000 
90,000-
2,280,000 
CA 47% 
NCA 53% 
< 1/2 AS  250,000 
30,000-
890,000 
870,000 
350,000-
1,790,000 
Case 
4 
0 90,000 0-520,000 CA 100% < 1/2 AS  < 1/2 AS  380,000 
100,000-
960,000 
Case 
5 
60/g dry 110,000 
3,000-
630,000 
Chr 100% 110,000 3,000-630,000 < 1/2 AS  680,000 
250,000-
1,470,000 
Case 
6 
0 140,000 
20,000-
690,000 
CA 33% 
NCA 67% 
< 1/2 AS  100,000 3,000-530,000 860,000 
390,000-
1,640,000 
Case 
7 
0 60,000 
4,000-
690,000 
CA 100% 120,000 4,000-690,000 < 1/2 AS  250,000 30,000-890,000 
Case 
8 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  < 1/2 AS  
Case 
9 
0 1,900,000 
800,000-
3,680,000 
Chr 12% 
CA 38% 
NCA 50% 
470,000 
60,000-
1,680,000 
< 1/2 AS  2,800,000 
1,450,000-
4,890,000 
Case 
10 
0 < 1/2 AS   310,000 
60,000-
900,000 
110,000 3,000-570,000 1,100,000 
560,000-
2,010,000 
Case 
11 
0 1,110,000 
620,000-
2,080,000 
Chr 91% 
CA 9% 
< 1/2 AS  < 1/2 AS  900,000 
410,000-
1,700,000 
Case 
12 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  460,000 
130,000-
1,180,000 
Case 
13 
0 120,000 
3,000-
640,000 
Chr 100% < 1/2 AS  < 1/2 AS  1,500,000 
800,000-
2,570,000 
Case 
14 
0 200,000 
20,000-
720,000 
Chr 50% 
CA 50% 
< 1/2 AS  < 1/2 AS  640,000 
210,000-
1,490,000 
Case 
15 
0 < 1/2 AS   130,000 4,000-720,000 < 1/2 AS  260,000 30,000-930,000 
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Table 2 cnt: main results of the LM and SEM analyses. 
 
AB 
(LM 
count) 
ASBESTOS FIBERS TALC FIBERS TITANIUM DIOXIDE OTHER FIBERS 
SEM burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
Fibers 
type 
SEM Burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
SEM Burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
SEM Burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
Case 
16 
110/g 
dry 
60,000 
3,000-
620,000 
CA 100% 450,000 
120,000-
1,140,000 
110,000 3,000-620,000 110,000 3,000-620,000 
Case 
17 
0 190,000 
30,000-
930,000 
CA 100% 260,000 
30,000-
930,000 
< 1/2 AS  380,000 
80,000-
1,120,000 
Case 
18 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  370,000 
80,000-
1,080,000 
Case 
19 
0 < 1/2 AS   < 1/2 AS  100,000 3,000-530,000 380,000 
80,000-
1,110,000 
Case 
20 
60/g dry 170,000 
20,000-
620,000 
Chr 50% 
NCA 50% 
130,000 4,000-710,000 < 1/2 AS  430,000 
140,000-
1,000,000 
Case 
21 
0 210,000 
30,000-
1,020,000 
NCA 
100% 
560,000 
150,000-
1,440,000 
< 1/2 AS  850,000 
310,000-
1,840,000 
Case 
22 
0 520,000 
170,000-
1,200,000 
Chr 50% 
CA 50% 
100,000 3,000-580,000 < 1/2 AS  < 1/2 AS  
Case 
23 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  170,000 20,000-610,000 
Case 
24 
0 < 1/2 AS   170,000 
20,000-
620,000 
< 1/2 AS  770,000 
350,000-
1,460,000 
Case 
25 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  130,000 4,000-700,000 
Case 
26 
 
20/g dry 
 
120,000 
4,000-
690,000 
NCA 
100% 
860,000 
350,000-
1,780,000 
< 1/2 AS  370,000 
80,000-
1,080,000 
Case 
27 
0 < 1/2 AS   130,000 4,000-700,000 < 1/2 AS  250,000 30,000-920,000 
Case 
28 
0 500,000 
140,000-
1,280,000 
Chr 50% 
NCA 50% 
120,000 4,000-690,000 < 1/2 AS  500,000 
140,000-
1,280,000 
Case 
29 
0 400,000 
80,000-
1,160,000 
Chr 67% 
CA 33% 
< 1/2 AS  < 1/2 AS  920,000 
370,000-
1,900,000 
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Table 2 cnt: main results of the LM and SEM analyses. 
 
AB 
(LM 
count) 
ASBESTOS FIBERS TALC FIBERS TITANIUM DIOXIDE OTHER FIBERS 
SEM burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
Fibers 
type 
SEM Burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
SEM burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
SEM burden 
(ff/g dry) 
95% CI  
(ff/g dry) 
Case 
30 
0 630,000 
200,000-
1,470,000 
CA 80% 
NCA 20% 
< 1/2 AS  < 1/2 AS  630,000 
200,000-
1,470,000 
Case 
31 
0 < 1/2 AS   920,000 
300,000-
2,150,000 
< 1/2 AS  1,100,000 
410,000-
2,400,000 
Case 
32 
0 500,000 
140,000-
1,280,000 
CA 50% 
NCA 50% 
1,400,000 
690,000-
2,470,000 
250,000 
30,000-
910,000 
1,600,000 
870,000-
2,790,000 
Case 
33 
0 120,000 
4,000-
660,000 
CA 100% < 1/2 AS  260,000 
30,000-
930,000 
470,000 
130,000-
1,210,000 
Case 
34 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  670,000 
290,000-
1,320,000 
Case 
35 
0 < 1/2 AS   < 1/2 AS  130,000 4,000-740,000 400,000 
80,000-
1,170,000 
Case 
36 
0 130,000 
4,000-
740,000 
CA 100% 260,000 
30,000-
960,000 
< 1/2 AS  130,000 4,000-740,000 
Case 
37 
0 230,000 
30,000-
830,000 
CA 50% 
NCA 50% 
120,000 3,000-640,000 120,000 3,000-640,000 810,000 
320,000-
1,660,000 
Case 
38 
0 100,000 
3,000-
550,000 
NCA 
100% 
500,000 
160,000-
1,160,000 
100,000 3,000-550,000 1,100,000 
540,000-
1,950,000 
Case 
39 
10/g dry 1,300,000 
730,000-
2,250,000 
CA 7% 
NCA 93% 
760,000 
330,000-
1,510,000 
100,000 3,000-530,000 2,820,000 
1,450,000-
4,900,000 
Case 
40 
30/g dry 2,000,000 
1,150,000-
3,270,000 
Chr 100% 130,000 4,000-700,000 < 1/2 AS  880,000 
350,000-
1,820,000 
Case 
41 
0 100,000 
3,000-
540,000 
NCA 
100% 
100,000 3,000-540,000 100,000 3,000-540,000 680,000 
270,000-
1,400,000 
Case 
42 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  770,000 
310,000-
1,580,000 
Case 
43 
20/g dry 670,000 
230,000-
1,350,000 
NCA 
100% 
2,400,000 
1,290,000-
4,150,000 
< 1/2 AS  1,100,000 
570,000-
2,040,000 
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Table 2 cnt: main results of the LM and SEM analyses. 
 
AB 
(LM 
count) 
ASBESTOS FIBERS TALC FIBERS TITANIUM DIOXIDE OTHER FIBERS 
SEM burden 
(ff/g dry) 
95% CI 
(ff/g dry) 
Fibers 
type 
SEM burden 
(ff/g dry) 
95% CI 
(ff/g dry) 
SEM burden 
(ff/g dry) 
95% CI 
(ff/g dry) 
SEM burden 
(ff/g dry) 
95% CI 
(ff/g dry) 
Case 
44 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  690,000 
220,000-
1,620,000 
Case 
45 
0 < 1/2 AS   < 1/2 AS  90,000 3,000-480,000 610,000 
240,000-
1,250,000 
Case 
46 
0 100,000 
3,000-
560,000 
NCA 
100% 
200,000 
20,000-
730,000 
< 1/2 AS  500,000 
160,000-
1,180,000 
Case 
47 
0 < 1/2 AS   140,000 4,000-760,000 < 1/2 AS  680,000 
220,000-
1,600,000 
Case 
48 
0 < 1/2 AS   90,000 3,000-500,000 < 1/2 AS  1,300,000 
750,000-
2,200,000 
Case 
49 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  120,000 4,000-680,000 
Case 
50 
0 < 1/2 AS   < 1/2 AS  < 1/2 AS  490,000 
160,000-
1,150,000 
Case 
51 
0 260,000 
30,000-
960,000 
CA 100% < 1/2 AS  < 1/2 AS  400,000 
80,000-
1,160,000 
Case 
52 
0 290,000 
30,000-
1,040,000 
NCA 
100% 
430,000 
90,000-
1,260,000 
290,000 
10,000-
1,590,000 
1,400,000 
690,000-
2,630,000 
Case 
53 
0 120,000 
4,000-
670,000 
NCA 
100% 
120,000 4,000-670,000 < 1/2 AS  240,000 30,000-870,000 
Case 
54 
0 150,000 
5,000-
850,000 
CA 100% 1,100,000 
430,000-
2,200,000 
< 1/2 AS  1,500,000 
730,000-
2,800,000 
Case 
55 
0 40,000 
3,000-
470,000 
CA 100% 330,000 
90,000-
860,000 
< 1/2 AS  330,000 90,000-860,000 
 
LM = Light Microscope, SEM = Scanning Electron Microscope. 
95% CI = 95% Confidence Interval. AS = Analytical Sensibility. 
Chr = Chrysotile, CA = Commercial Amphibole, NCA = Non-Commercial Amphibole.. 
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Asbestos fibers were SEM-detected in 35 cases (63.6%), while 20 cases had an 
asbestos burden lower than the ½ analytical sensibility. 60% of cases with an asbestos 
burden lower than the ½ analytical sensibility was represented by subjects younger than 
30 years. Three cases showed a pure chrysotile burden, 24 cases a pure amphibole 
burden and 8 cases a mixed chrysotile + amphibole burden. Chrysotile fibers were thus 
detected in 20% of all the experimental cases, whereas amphibole fibers in 58.2%. In 
cases showing a mixed chrysotile and amphibole burden, the chrysotile amount ranged 
from 12% to 91% of the total burden and was joined by a Non-Commercial Amphiboles 
burden in 50% of subjects and by a Commercial Amphiboles burden in 62.5%. Among 
the cases showing a detectable amphibole burden (either pure or chrysotile-mixed), 13 
cases had a pure Commercial Amphiboles burden, 11 cases had a pure Non-Commercial 
Amphiboles burden and 8 cases had a combined Commercial + Non-Commercial 
Amphiboles burden. Commercial Amphibole fibers were detected in 40% of all the 
experimental cases, whereas Non-Commercial Amphibole fibers in 34.5%. The Non-
Commercial Amphiboles burden was mainly represented by tremolite fibers (92.5%). 
The median values and interquartile ranges for the chrysotile burden and the 
amphiboles burden in the whole population are reported in Table 3. The maximum 
estimated asbestos burden was 2,000,000 ff/g dry (100% chrysotile fibers), while the 
maximum estimated amphiboles burden was 1,672,000 ff/g dry. 
 
Table 3: global asbestos burden versus chrysotile burden versus amphiboles 
burden. 
 Asbestos fibers Chrysotile fibers Amphibole fibers 
Median value 
(ff/g dry) 
110,000 51,600 91,600 
Interquartile 
range (ff/g dry) 
62,250-275,000 46,600-65,000 60,000-180,000 
 
Based on the Helsinki Criteria for the occupational exposure to asbestos, 3 cases 
showed an amphibole burden higher than the established cut off for fibers longer than 1 
µm (1,000,000 ff/g dry) and other 10 cases showed an amphibole burden greater than 
100,000 ff/g dry for fibers longer than 5 µm. 
Figure 1 illustrates the asbestos burden for all subjects separately in males and 
females. The median value in females was 150,000 ff/g dry (IQR 63,000-400,000) while 
it was 95,750 (IQR 61,500-170,000) in males (p = 0.31). 
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Figure 1: Box-plot of asbestos burden in the whole population, by gender 
(F = females, M = males). 
 
 
Figure 2 shows the association between asbestos burden and age at death in all 
subjects: the percent change in asbestos burden per 1-year increase in age at death was 
2.81 (95% CI 1.54-4.09, p < 0.001) indicating a positive trend with increasing age. 
 
When we considered the amphiboles burden variation according to the sex 
variable (Figure 3), the differences were not statistically significant (p = 0,22). The 
median values were 120,000 (IQR 61,600-260,000) in females and 77,500 (IQR 58,300-
130,000) in males. 
The positive trend with age at death was confirmed (Figure 4): percent change in 
amphiboles burden per 1-year increase in age at death = 2.33 (95% CI 1.22-3.45, p < 
0.001). 
If we consider only subjects (52 cases) having an amphibole SEM-counting lower 
than the 1,000,000 ff/g dry cut off for occupational exposure (figure 5 and 6) the results 
did not consistently change. As predictable, the annual percent  increase for the lung 
amphiboles burden is much lower (1.16%, see Figure 6) after excluding the few cases 
having an extremely high SEM amphibole counting. 
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Figure 2: relationship between asbestos burden and age at death in all subjects. 
 
 
Figure 3: Box-plot of amphiboles burden in the whole population, by gender 
(F = females; M = males). 
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Figure 4: relationship between amphiboles burden and age at death in the whole 
population. 
 
 
Figure 5: Box-plot of amphiboles burden in the 52 cases with < 1,000,000 
amphiboles ff/g dry stratified by gender (F = females; M = males). 
 
250,000 
100,000 
60,000 
120,000 
58,300 
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Figure 6: relationship between amphiboles burden and age at death in cases < 
1,000,000 amphiboles ff/g dry. 
 
 
Table 4 details the main characteristics of the 13 cases having an asbestos burden 
above the Helsinki cut offs for the occupational exposure to asbestos (10 cases having > 
100,000 amphibole fibers longer than 5 µm/g dry and 3 cases having > 1,000,000 
amphibole fibers longer than 1 µm/g dry). The mean age was 57.5 ± 19.8 years, 
significantly higher (p 0.013) than the subgroup having an amphiboles burden lower 
than the Helsinki Criteria for occupational exposure. The distribution by gender, 
residential district and smoking habits did not differ. Three cases showed a positive 
Asbestos Bodies counting in LM ranging from 10 AB/g dry to 20 AB/g dry. 
Because of the poor available notations about the work histories of the 
experimental cases, it was not possible to carefully analyze the subgroup above the 
Helsinki Criteria according to singular job experiences and singular occupational 
exposures to asbestos: it is nonetheless remarkable the presence inside such subgroup of 
a retired automotive industry worker and of a retired truck driver. Further and more 
detailed investigations about the lifetime work experiences of the cases AB positive and 
the cases above the Helsinki Criteria have been started during the final phase of the 
present PhD study but have not yet been completed. This approach has been made 
possible thanks to collaboration with OCCAM (OCcupational CAncer Monitoring) that  
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Table 4: main characteristics of the 13 cases having and amphibole burden higher than the Helsinki Criteria for occupational exposure. 
 
 
Age 
Sex 
Amphiboles 
ff/g dry 
AB/g dry 
Talc 
ff/g dry 
Other inorganic 
ff/g dry 
Residence 
Birthplace 
Smoking habit Work 
Case 1 
42 
F 
fibers longer than 
5 µm: 400,000 
0 570,000 1,500,000 
NW 
Milan 
Non Smoker Housewife 
Case 6 
72 
M 
fibers longer than 
5 µm: 140,000 
0 < ½ x AS 860,000 
NE 
Syracuse, Italy 
> 20 
Retired 
(clerical worker) 
Case 17 
48 
F 
fibers longer than 
5 µm: 190,000 
0 260,000 380,000 
S 
Milan 
Non Smoker Housewife (graphic-designer) 
Case 21 
79 
F 
fibers longer than 
5 µm: 105,000 
0 560,000 850,000 
S 
Milan 
1-10 Retired 
Case 32 
81 
F 
fibers longer than 
5 µm: 200,000 
0 1,400,000 1,600,000 
S 
Turin, Italy 
Not Available Retired (housewife) 
Case 37 
64 
M 
fibers longer than 
5 µm: 115,000 
0 120,000 810,000 
NW 
Pavia, Italy 
1-10 
Retired 
(truck driver) 
Case 43 
80 
F 
fibers longer than 
5 µm: 286,000 
20 2,400,000 1,100,000 
NW 
Rome, Italy 
Non Smoker Retired (kindergarten teacher) 
Case 52 
55 
F 
fibers longer than 
5 µm: 145,000 
0 430,000 1,400,000 
S 
Bari, Milan 
> 20 Clerical worker 
Case 53 
21 
M 
fibers longer than 
5 µm: 120,000 
0 120,000 240,000 
NW 
Milan 
Non Smoker Clerical worker 
Case 54 
35 
F 
fibers longer than 
5 µm: 150,000 
0 1,100,000 1,500,000 
S 
Naples, Italy 
Non Smoker 
Long term unemployed 
(housewife) 
 
Case 3 
74 
M 
fibers longer than 
1 µm: 1,200,000 
10 < ½ x AS 870,000 
S 
Milan 
> 20 
Retired 
(automotive industry worker) 
Case 9 
64 
F 
fibers longer than 
1 µm: 1,672,000 
0 470,000 2,800,000 
NE 
Lecco, Italy 
> 20 Secretary 
Case 39 
83 
F 
fibers longer than 
1 µm: 1,300,000 
10 760,000 2,820,000 
NE 
Milan 
Not Available 
Retired 
(shop-keeper) 
 
AB = morphologically typical Asbestos Bodies. M = male, F = female. AS = Analytical Sensibility. NW = North West, NE = North East, S = South.
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investigates occupational cancer risk by industrial sectors. 
When we analyzed the asbestos lung burden across the four residence districts in 
Milan (North East, North West, South and City Centre), the birthplace (Milan versus 
outside) and the smoking habits (ever smokers versus non-smokers), no statistical 
differences were found. 
A special analytical focus was about the dimensions of the detected asbestos 
fibers. Table 5 summarizes the analytical results about asbestos fiber dimensions. 
From the whole experimental population a global amount of 111 asbestos fibers 
were measured by SEM: 40 Non-Commercial Amphibole fibers, 32 Commercial 
Amphibole fibers and 39 chrysotile fibers. Chrysotile fibers were significantly shorter 
and thinner than amphiboles fibers, while Commercial Amphibole fibers were 
significantly thinner than the Non-Commercial Amphibole fibers. 
The mean aspect ratio (length/width) value decreased from the chrysotile fibers to 
the Commercial Amphibole fibers and yet to the Non-Commercial Amphibole fibers, 
about 70% of the detected chrysotile fibers showing a diameter < 0,1 µm versus the 
25% of the Commercial Amphibole fibers and the 0% of the Non-Commercial 
Amphibole fibers. An aspect ratio lower than 10 was recorded in 0% of chrysotile 
fibers, in 12.5% of Commercial Amphibole fibers and in 40% of Non-Commercial 
Amphibole fibers. Only 13.5% of all asbestos fibers were longer than 10 µm, while 
about 60% was shorter than 5 µm and 47.7% were both ultrashort and ultrathin fibers 
(length < 5 µm and diameter < 0.25 µm). Less than 10% of all detected asbestos fibers 
were Stanton fibers (fibers longer than 8 µm and thinner than 0.25 µm), Lippmann 
fibers variant 1 (fibers longer than 5 µm and thinner than 0.1 µm) or Lippmann fibers 
variant 2 (fibers longer than 10 µm and thinner than 0.15 µm). A further analysis was 
performed about the prevalence of the long asbestos fibers: 34% of the whole 
experimental population had no asbestos fibers longer than 5 µm, while 56% had no 
asbestos fibers longer than 10 µm. About 80% of the whole population had no Stanton 
fibers, while nearly 90% showed no Lippmann fibers variant 1 or Lippmann fibers 
variant 2. 
 
Even though the distinction between true asbestiform fibers and non-asbestiform 
cleavage fragments was not a declared focus of the present work, data from table 5 
show the relative amount of Commercial Amphiboles and Non-Commercial 
Amphiboles respectively fitting the American Society for Testing and Materials criteria 
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for class 2 fibers (ASTM class 2 fibers hypothesis: fibers longer than 10 µm or thinner 
than 1 µm being true asbestiform fibers) [144]. The very high percentage of fibers with 
a width < 1 µm across all the subgroups allows here the reader to equalize the official 
ASTM class 2 criteria to the revision hypothesis later advanced -but finally rejected- by 
the Workplace ASTM subcommittee (fibers longer than 10 µm and thinner than 1 µm 
being true asbestiform fibers). The previous notation about the percentage of fibers 
having an aspect ratio lower than 10 also answers the claim about this aspect ratio value 
to be a reliable cut off between true asbestiform fibers (AR usually > 10) and cleavage 
fragments (AR usually < 10) [145]. 
 
Table 5: dimensional analysis of the detected asbestos fibers (CA = Commercial 
Amphiboles; NCA = Non-Commercial Amphiboles). 
 
All asbestos 
fibers 
Chrysotile fibers CA fibers NCA fibers 
Length x 
diameter µm: 
geometric mean 
values 
(95% CI) 
4.19 (2.49-5.89) 
x 
0.19 (0.14-0.24)  
2.74 (2.19-3.43) 
x 
0.09 (0.08-0.10) 
4.86 (3.28-7.20) 
x 
0.18 (0.14-0.23)  
5.65 (4.39-7.28) 
x 
0.47 (0.40-0.57) 
Mean aspect 
ratio 
(length/width) 
20.6 30.7 26.9 11.25 
% of fibers ≥ 10 
μm in length 
13.5% 5.1% 21.8% 15% 
% of fibers ≥ 5 
μm in length 
37.8% 20.5% 34.3% 57.5% 
% of fibers < 1 
µm in length 
94.6% 100% 96.8% 87.5% 
% of fibers ≤ 0.1 
μm in width 
31.5% 69.3% 25% 0% 
% of Stanton 
fibers  
7.2% 7.7% 12.5% 2.5% 
% of Lippmann 
fibers 
(hypothesis 1) 
4.5% 10.2% 3.1% 0% 
% of Lippmann 
fibers 
(hypothesis 2) 
3.6% 5.1% 6.2% 0% 
  
The SEM analysis also extended to the counting of talc fibers, titanium-containing 
fibers and inorganic fibers other than asbestos. 
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Talc fibers were positively detected in 56.4% of cases, titanium-containing fibers 
in 25.5% and other inorganic fibers other than asbestos in 96.4%. The median values 
from the whole experimental population were respectively 110,000 ff/g dry 
(interquartile range 50,750-285,000 ff/g dry), 51,500 ff/g dry (interquartile range 
48,000-81,500 ff/g dry) and 640,000 ff/g dry (interquartile range 375,000-910,000 ff/g 
dry). 
No statistical influence of the variables sex, residential district, birthplace and 
smoking habit was observed on the median values of talc, titanium and other inorganic 
fibers burdens. 
Figures 7 and 8 respectively illustrate the relationships between the talc fibers 
burden and the miscellaneous inorganic fibers burden with age at death. The percent 
change per 1-year increase in age at death was 1.74 (95% CI 0.29-3.22, p = 0,020) for 
the talc burden and 0.96 (95% CI 0.24-2.16, p = 0,114) for the other inorganic fibers 
burden. 
 
Figure 7: relationship between talc fibers burden and age at death in the whole 
population.  
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Figure 8: relationship between other inorganic fibers burden and age at death in 
the whole population. 
 
 
 
Figure 9: asbestos burden versus talc burden versus titanium burden versus other 
inorganic fibers burden in the whole population. 
 
 
34 
 
DISCUSSION AND CONCLUSIONS 
 
We investigated the lung asbestos burden in a sample of necropsies collected 
between 2009-2011 at the Institute of Forensic Medicine of Milan. The study population 
included 55 subjects residents in Milan at the time of death, stratified by gender (30 
males and 25 females) and age (15 cases ≤ 30 years, 21 cases 31-60 years and 19 cases 
> 60 years). The study population can be considered a representative sample of the 
Milan resident population, yet avoiding the anagraphic biases usually connected with 
consecutive and unselected necroscopic series (series younger and much more male-
oriented than the whole background population). 
 
Milan is a post-industrial and tertiary-oriented town, far enough from relevant 
natural sources of asbestos dust and historically free from major asbestos primary 
manufactures. However, Milan is also a high-traffic metropolitan town widely scattered 
by either professional and residential buildings still containing asbestos-rich 
components (asbestos estimated volume in Milan territory at September 2008: 784,808 
m
3
) [146], that is Milan is not a town expected free from asbestos pollution. The Milan 
surroundings are mainly industrial on the north side and mainly rural on the south side. 
Based on environmental measurements performed in 1991, the background 
asbestos-pollution in the city was mainly a chrysotile-pollution with prevalence of 
ultrashort and ultrathin fibers: such background pollution tended to be constant across 
the four seasons of the year and was not influenced by the vehicular traffic rates and by 
the land use in the different urban districts [147]. Milan asbestos pollution (mean value 
12,1 ± 4,6 ff/L) was significantly  lower than the background pollution of a small town 
hosting primary asbestos manufactures (Casale Monferrato: 48,4 ± 33,5 ff/L) but was 
higher than the environmental pollution from other Italian medium-sized towns 
(Brescia: 5,6 ± 1,5 ff/L, Ancona: 6,00 ± 1,2 ff/L, Firenze: 1,8 ± 1,0 ff/L, Bologna 3,3 ± 
3,6 ff/L) [147] and also from Rome [148]. Based on official data from the Lombardy 
Region and from the Lombardy ARPA Laboratories [146], repeated measurements 
between 1999 and 2008 showed mean asbestos atmospheric level always lower than 
0,07 ff/L for fibers longer than 5 µm. The asbestos environmental burden was 
constituted by 65% chrysotile fibers and 35% amphibole fibers. In 2008 the mean 
asbestos atmospheric level for ultrathin fibers was lower than 2,5 ff/L. 
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In short, Milan is nowadays a 1,300,000 inhabitants town showing a decreasing 
background level of secondary asbestos-pollution with infrequent spikes of primary 
asbestos-pollution and a strongly prevalent non-occupational asbestos exposure of the 
resident people. As already suggested by other authors in different industrialized 
countries [254], the younger class people today living in Milan (people born or grown 
up after the 1992 asbestos ban) can be considered to be ever exposed only to a light 
secondary asbestos pollution, while people belonging to the 30-60 years and the > 60 
years classes must be considered to have remotely suffered more intense asbestos 
exposures either in occupational or non-occupational circumstances. 
 
More than 60% of our population presented SEM-detectable asbestos fibers inside 
the lung parenchyma, with amphiboles fibers being more frequently detected than 
chrysotile fibers (58.2% of cases showing detectable amphibole fibers versus 20% 
showing detectable chrysotile fibers). Commercial and Non-Commercial Amphiboles 
were equally represented, the former coming from the indoor and outdoor releasing 
from asbestos-containing materials and the latter mainly originating as a natural 
contaminant of either the industrial chrysotile or the cosmetic talc [149-153]. The 
greater biopersistence of the amphiboles rather than chrysotile may explain the higher 
detection frequency for amphibole fibers even in the sample from a low-amphibole and 
a high-chrysotile polluted town. Such a ratio between amphiboles and chrysotile 
positive cases should also be prudentially analyzed in the suggested perspective of an 
intrinsic SEM bias towards the underestimation of chrysotile fibers [43,154]. 
The asbestos lung burden represents the final result of a lifetime dynamic 
accumulation as suggested by our findings that showed a linear positive trend of the 
lung asbestos burden with increasing age. In addition, 80% of study subjects younger 
than 30 years had an asbestos lung burden lower than the SEM analytical sensitivity. As 
stated before, the ≤ 30 years old people and the > 30 years old people analyzed in our 
study probably faced different pattern of daily asbestos exposures, with older subjects 
well crossing the asbestos-exploitation era: the reported “age-lung fibers burden” 
relationship should therefore be analyzed also remembering that > 30 years people do 
not represent an automatic reliable forecast for younger subjects. 
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About 5% (3 cases) exceeds the Helsinki amphiboles 1,000,000 ff/g dry cut off for 
occupational exposure. For one case an occupational exposure to asbestos is plausible: 
he worked in an automotive industry well-known as contaminated by asbestos. 
Combining the two amphiboles statements from the 1997 Helsinki Consensus 
Report about probabilistic occupational asbestos exposures (1,000,000 ff/g dry cut off 
for all amphibole fibers and 100,000 ff/g dry cut off for amphibole fibers longer than 5 
µm), 23.6% of our population would set above the suggested threshold values. A 
thorough explanation of these findings is however limited by the lack of a detailed 
lifetime work history for every case enrolled in the experimental population. All the 
attempts performed so far to investigate the occupational exposure of our cases (live 
pre-autoptic interviews + phone interviews with the subject’s relatives) did not get 
satisfactory data. An ongoing search is in progress to obtain data on past work histories 
thanks to the collaboration with OCCAM (OCcupational CAncer Monitoring) that 
investigates occupational cancer risk by industrial sectors. For each case a linkage with 
social security files available at the National Social Security Institute from 1974 has 
been planned in order to obtain data on past employment. For each year of employment 
the employing firm, its economic branch and the white collar versus blue collar status 
are available. 
However, the evidence of more than 20% of our cases having an amphibole count 
higher than the Helsinki cut off for occupational exposure to asbestos suggests the need 
to develop reference values for the residents in the city of Milan. The Helsinki 
Document itself actually stimulates any asbestos-dealing laboratory to the production of 
its own reference values from the pertinent background population and also states that 
the intrinsic reliability of a reference population comes from the stable evidence of a 
median asbestos burden for occupationally exposed people substantially higher than the 
corresponding reference population median burden [25]. 
The 6 analytical teams referring to the European Respiratory Society Asbestos 
Task Force published in 1998 their own reference values for the background 
populations, 5 teams not declaring any reference value for the amphibole fibers longer 
than 5 µm and just 1 team declaring the reference value 180,000 ff/g dry for the 
amphibole fibers longer than 5 µm [32]. Matching the analytical evidences of the 
present work with the 180,000 ff/g dry cut off for amphibole fibers longer than 5 µm, 
just 12.7% of our population (6 cases) would be labelled as having an abnormal lung 
retention of amphibole dust. 
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To further complicate matters, the Helsinki Report seems to equalize SEM and 
TEM techniques, whereas some authors partially explain the well-known inter-
laboratory variability in asbestos burden estimations with the different performance of 
the currently available microscopic counting techniques [27,89,155]. Even though a 
general consensus about the 1,000,000 ff/g dry cut off for all the amphibole fibers do 
exist, such vigorously debated problems reinforce the need for the proper definition of 
reliable reference values by every single laboratory performing asbestos counting 
analyses and recommend the use of external reference values just for speculative 
purposes. 
 
In our population the variables sex, residential district, birthplace and smoking 
habit did not significantly influence the median value of the asbestos burden. Previous 
studies already showed no influence of gender [238,241,243,257] and smoking habit 
[254] on the asbestos lung burden from the general population.  
 
A comparison of the asbestos lung burden in the general populations from 
different countries or cities [33,99,127,181,237-259] is made difficult by the great 
variability related to the environmental characteristics of the study areas, the period ob 
observation, the selection criteria and the size of the examined population, the employed 
analytical techniques and the counting rules [156]. Such variability further underlines 
the need to build local and specific reference values. 
 
About 50% of the asbestos fibers recovered from the lung parenchyma of our 
population was composed by ultrashort and ultrathin fibers, while fibers longer than 10 
µm represented a fraction slightly above 10%. Such evidence matches well with the 
already discussed Milan environmental asbestos pollution [147], but also suggests an 
extraordinary biopersistence of the long amphibole fibers [157] (80% of the detected 
fibers longer than 5 µm being in fact amphibole fibers). There is no definite way to infer 
from the SEM images of a lung fiber its past splitting behaviour, that is a SEM image 
cannot reliably distinguish “native” fibers from fibrous fragments generated inside the 
lung parenchyma. Chrysotile is considered the asbestos variety most susceptible to 
intrapulmonary splitting, its mean dimensions being thus regularly expected as 
considerably lower than those of amphiboles. Among the asbestos fibers recovered from 
our experimental cases, chrysotile fibers were significantly shorter and thinner than 
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amphibole fibers and Non-Commercial Amphibole fibers are thicker than the 
commercial ones. 
In substantial agreement with previous independent observations (Table 6), the 
chrysotile fibers showed a very short mean length and a thin diameter, the Non-
Commercial Amphibole fibers differed from the Commercial Asbestos fibers because of 
a lower aspect ratio and all the asbestos varieties increased their mean aspect ratios 
along with the increasing of their mean lengths. 
In the lungs of the examined population there was just a minimal contamination 
from (asbestos) fibers traditionally supposed to hold a fibrogenic [158,159] or a 
carcinogenic metric [160,161]. In our experimental cases the typical asbestos burden 
was mainly made up by short and thin fibers yet to be definitely understood in their 
oncogenic potential [150,162-168]. 
 
The Asbestos Bodies prevalence in our experimental series was relatively low in 
agreement with the small fraction of asbestos fibers longer than 10 µm detected in the 
SEM analyses [56,76]. The Asbestos Bodies concentration in all the AB positive cases 
was well below the Helsinki Criteria for inferring an asbestos occupational exposure 
and also well below the 100 AB/g wet cut off for detecting AB in routine histological 
analysis of the lung [169,170]. The detected range of AB burden in positive cases was 
in full agreement with the previous literature statements about a mean general 
population AB burden lower than 20-50 AB/g wet and lower than 200-500 AB/g dry 
[56,76,171-173,227]. In the present study, only the morphologically typical Asbestos 
Bodies were counted and no investigation about the chemical composition of the Bodies 
core was performed. Even though a typical microscopic AB-morphology correlates well 
with the asbestos composition of the fibrous core [56,65,66,175,176], the absence of 
chemical analyses on the core of the detected bodies prudentially recommends to 
underline that the used label “morphologically typical Asbestos Body” does not mean 
“body with an assessed asbestos core”. 
No Asbestos Bodies were found among the cases younger than 30 years. Being 
the Asbestos Bodies formation a relatively rapid process [58,184], such evidence can be 
better explained by a theory focused on the decrease of long airborne asbestos fibers in 
the last 20-30 years rather than by a theory suggesting the lack of sufficient time for 
creating Asbestos Bodies in young-dying people. However, the positive relationship 
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between the Asbestos Bodies prevalence and the increasing age is an inconstant finding 
across the available scientific literature [53,177,185,186]. 
 
A comparison between the findings in our study population and the results 
obtained by the same SEM laboratory in two distinct populations of Italian asbestos-
exposed workers [142,143] was also performed. This comparison was not a pure 
juxtaposition between occupational- and environmental-exposed subjects (as 
recommended by the Helsinki Report to validate a reference value for background 
asbestos population), because the two occupational-exposed groups were in reality 
made of workers affected by asbestos-related diseases. 
The two occupational-exposed population respectively included 11 mesothelioma 
cases among asbestos- and nonasbestos-textile workers [143] and 12 cases with 
asbestos-related diseases (5 mesotheliomas, 4 lung cancers, 1 asbestosis + pleural 
plaques and 2 pure pleural plaques) among asbestos-cement workers [142]. 
In the former group the highest values of asbestos fibers were detected in the 
asbestos-textile subgroup (4 cases) and in 3 cases employed in jute recycling with 
concentrations ranging between 9,1 and 397 millions ff/g dry, well above the range 
observed in our study population. The total fiber concentrations in the other 4 non 
asbestos-textile workers (silk and cotton production workers) ranged from 0,33 to 1,2 
millions ff/g dry and overlapped with the concentrations observed in our population. 
Among the asbestos-cement workers 11 out of the 12 examined cases had an 
asbestos lung burden higher than 2,5 millions ff/g dry. Only 1 subject affected by lung 
cancer had a total fiber concentration of 1,32 millions ff/g dry, a value lower than our 
maximum measured concentration of 2,0 millions ff/g dry. 
As regard the type of asbestos fibers, in both the occupational-exposed groups a 
100% amphibole fibers detection frequency was observed (versus 58.2% in our 
population). Chrysotile fibers were detected in 20% of our population, in 25% of the 
asbestos-cement workers and in 72.8% of the asbestos-textile workers series. 
 
In substantial agreement with other international experiences about the general 
population [89,187], the fibers lung burden from our experimental cases also comprised 
talc fibers, titanium-containing fibers and other inorganic fibers and the non-asbestos 
fibers burden greatly outnumbered the asbestos fibers burden. Talc is a well-known 
human fibrogenic pathogen [78,188-191] and in our experimental series the median 
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value of the talc fibers burden appears to be very similar to the median value of the 
asbestos fibers burden. The SEM analysis did not allow a definite distinction among the 
inorganic fibers other than asbestos and a TEM analysis would be therefore needed to 
properly investigate such component of the fibrous lung burden and eventually to focus 
on the Man Made Vitreous Fibers and the Refractory Ceramic Fibers subgroups 
[13,192,193]. 
 
The present work aimed at describing the asbestos lung burden from a 
necroscopic sample of the people today living in Milan, thus giving a first contribution 
to the creation of reliable reference values for the asbestos lung burden of the Milan 
population. 
To establish reliable reference values for such analyses is at the same time 
mandatory for a good clinical and forensic practice but also very difficult to realize 
[89,194,195]. According to the European Respiratory Society Asbestos Task Force [32], 
the creation of reliable reference values for the asbestos lung burden estimations is a 
multistep task with contemporary focus on necroscopic series free from asbestos-related 
diseases and on surgical series from patients undergone lung surgery either for asbestos-
related pathology or not. In this perspective, the present work is just a first contribution 
to the creation of reliable reference values for the asbestos lung burden estimations and 
there is the pivotal need for further research on Milan lung surgical series. 
 
A better and thorough evaluation of the results from the present work will be done 
after improving the exposure history collection for all the 55 cases enrolled in the 
experimental population: as stated before, an ongoing research is in progress. 
 
The results of the present study are first of all influenced by the employed 
population selection criteria, sampling procedures, analytical techniques and counting 
rules. As a preliminary warrant about the reliability of the assessing results [196], all the 
pre-analytical and analytical steps have been performed by trained specialists according 
to published and shared methodologies and all the SEM-analyses (the only ones 
probably expected to produce the effective reference values for asbestos lung counting) 
have been performed at the certified Laboratory of the Environmental Protection 
Agency of Lombardy (ARPA). 
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The collected results come after about 20 years from the 1992 Italian asbestos ban 
and put together at least 2 subgroups of people probably facing in their lifetime a very 
different pattern of asbestos exposure (1
st
 age class people versus 2
nd
 and 3
rd
 age class 
people). After just 20 years from the total asbestos ban, the results from such a general 
investigation on the whole resident population have to be considered as intermediate 
evidences along a period of ever-decreasing environmental exposure to asbestos in 
Milan. The results from the present study need therefore to be updated in the future 
[196] to promptly detect any differences in the asbestos lung burden of the Milan 
residents after demographic increasing of the people having faced in their lifetime only 
very mild secondary asbestos pollution. This update will be another crucial factor for a 
good clinical and forensic practice about asbestos-related diseases. 
 
The typical fibrous lung content of Milan residents also comprises talc fibers, 
titanium-containing fibers and a great amount of inorganic fibers other than asbestos, 
talc and titanium. The global amount of fibers other than asbestos greatly outnumbers 
the asbestos lung content and the estimated median talc burden is very similar to the 
median asbestos burden. The miscellaneous group of the inorganic fibers other than 
asbestos, talc and titanium extends to the Man Made Vitreous Fibers and the Refractory 
Ceramic Fibers: such fibers need a further dedicated experimental focus by TEM-
analysis, as similarly do ultrathin and ultrashort asbestos fibers and also cleavage 
fragments from non-asbestiform amphiboles [144,145,149]. 
Available data suggest a progressive lifetime accumulation of all the major 
inorganic fiber types inside the lung parenchyma of the Milan inhabitants.
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Table 6: asbestos fibers dimension from 10 different studies about the general population. 
 
Chrysotile fibers CA fibers NCA fibers 
Churg et al 
1980 
[241] 
 
90% < 5 µm in length 
1.9% > 10 µm in length 
Mean AR for fibers < 5 µm in length: 61 
Mean AR for fibers 5-10 µm in length: 200 
Mean AR for fibers > 10 µm in length: 340 
25% < 5 µm in length 
20.6% > 10 µm in length 
Mean AR for fibers < 5 µm in length: 32 
Mean AR for fibers 5-10 µm in length: 68 
Mean AR for fibers > 10 µm in length: 160 
60% < 5 µm in length 
7.4% > 10 µm in length 
Mean AR for fibers < 5 µm in length: 18 
Mean AR for fibers 5-10 µm in length: 25 
Mean AR for fibers > 10 µm in length: 30 
Churg et al 
1986 
[247] 
94% < 5 µm in length 
1% > 10 µm in length 
Mean length 1.1 µm 
Mean AR 24 
 
For tremolite fibers 
92% < 5 µm in length 
0% > 10 µm in length 
Mean length 1.6 µm 
Mean AR 6.5 
Paoletti et al 
1991 
[183] 
For all asbestos fibers 
Length range 1-8 µm 
Mean length 3 µm 
Langer et al 
1994 
[234] 
99.4 % < 5 µm in length 
90.2% < 1 µm in length 
  
Magnani et 
al 
1998 
[181] 
 
For all amphiboles fibers 
Mean dimensions 11.7 x 0.40 µm 
Dodson et al 
1999 
[237] 
86.4% < 5 µm in length 
Mean dimensions 1.81 x 0.06 µm 
Mean AR 29.3 
For amosite fibers 
75% < 5 µm in length 
 
For crocidolite fibers 
100% < 5 µm in length 
For tremolite fibers 
89% < 5 µm in length 
Mean dimensions 2.40 x 0.26 µm 
Mean AR 9.11 
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Table 6 cnt: asbestos fibers dimension from 10 different studies about the general population. 
 Chrysotile fibers CA fibers NCA fibers 
Dodson et al 
2000 
[257] 
For all asbestos fibers 
Mean dimensions 2 x 0.15 µm 
Mean AR 13.9  
Tossavainen 
et al 
2000 
[258] 
Mean dimensions 2.2 x 0.08 µm   
McDonald 
et al 
2001 
[259] 
 3.5% of all amphibole fibers > 10 µm in length  
Present 
work 
For all asbestos fibers 
62.2% < 5 µm in length 
13.5% > 10 µm in length 
Mean dimensions 4.19 x 0.19 µm 
Mean AR 20.6 
79.5% < 5 µm in length 
5.1% > 10 µm in length 
Mean dimensions 2.74 x 0.09 µm 
Mean AR 30.7 
Mean AR for fibers < 5 µm in length 24.4 
Mean AR for fibers > 5 µm in length 74.9 
65.7% < 5 µm in length 
21.8% > 10 µm in length 
Mean dimensions 4.86 x 0.17 µm 
Mean AR 26.9 
Mean AR for fibers < 5 µm in length 16.3 
Mean AR for fibers > 5 µm in length 70.2 
42.5% < 5 µm in length 
15% > 10 µm in length 
Mean dimensions 5.65 x 0.47 µm 
Mean AR 11.25 
Mean AR for fibers < 5 µm in length 5.8 
Mean AR for fibers > 5 µm in length 31.2 
 
CA = Commercial Amphiboles, NCA = Non-Commercial Amphiboles. AR = Aspect Ratio. 
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SUMMARY 
 
The present study analyzed the asbestos lung burden from a necroscopic 
series of the Milan general population. The study was performed on 55 cases free 
from asbestos-related disease undergone a judicial autopsy at the Forensic 
Institute of Forensic Medicine of Milan in the period running from 2009 to 2011. 
For each study case multiple lung samples were digested and vacuum-
filtered on 0.2 µm pore size polycarbonate membranes and then were analyzed by 
both traditional Light Microscopy (for counting of morphologically typical 
Asbestos Bodies) and EDXA-Scanning Electron Microscopy (for counting of all 
asbestos fibers). The SEM-analysis also extended to the count of inorganic fibers 
other than asbestos. 
The Asbestos Bodies prevalence in the series was 14.5% with the positive 
cases having an AB count ranging from 10 to 110 AB/g dry. No Asbestos Bodies 
were found in the subjects younger than 30 years. 
Asbestos fibers were SEM-detected in 63.6% of the study cases, with a 
higher detection frequency for amphiboles than for chrysotile (58.2% versus 
20%). An asbestos content lower than the SEM analytical sensibility was found in 
80% of the subjects younger than 30 years. Commercial Amphiboles were 
detected as frequently as NonCommercial Amphiboles. NonCommercial 
amphiboles were mainly represented by tremolite fibers. 
The estimated median value was 110,000 ff/g dry (IQ range 62,250-275,000 
ff/g dry) for all the asbestos fibers, 91,600 ff/g dry (IQ range 60,000-180,000 ff/g 
dry) for the amphibole fibers and 51,600 ff/g dry (IQ range 46,600-65,000 ff/g 
dry) for the chrysotile fibers. 
The maximum estimated burden for all asbestos fibers was 2,000,000 ff/g 
dry. Thirteen cases showed an amphibole burden higher than the Helsinki cut offs 
for occupational exposure: three cases showed a total amphibole burden higher 
than 1,000,000 ff/g, while other 10 cases showed an amphibole burden for fibers 
longer than 5 µm higher than the 100,000 ff/g dry. 
A comparison was performed between our results and the results coming 
from two distinct occupational-exposed populations examined by the same SEM 
laboratory. The maximum measured asbestos burden in our population was lower 
than the minimum measured asbestos burden among asbestos-textile workers, jute 
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recycling workers and asbestos-cement workers. Just one asbestos-cement worker 
and 4 silk/cotton-textile workers showed asbestos lung concentrations overlapping 
our experimental results. 
A positive linear relationship was observed between asbestos lung burden 
and age at death. Sex, residential district, birthplace and smoking habit did not 
significantly influence the median asbestos lung burden. 
The mean dimension for the detected asbestos fibers was 4.19 x 0.19 µm 
with a 20.6 mean aspect ratio. Chrysotile fibers (mean dimension 2.74 x 0.09 µm) 
were significantly shorter and thinner than amphibole fibers, the NonCommercial 
Amphibole fibers (mean dimension 5.65 x 0.47 µm) being also significantly 
thicker than the Commercial Amphibole fibers (mean dimension 4.86 x 0.17 µm). 
Asbestos fibers traditionally supposed to be fibrogenic and carcinogenic in 
humans were very infrequently detected. 
The median talc burden was very similar to the median asbestos lung burden 
and the global non-asbestos fibers lung burden well outnumbered the asbestos 
fibers burden. Also for inorganic fibers other than asbestos a positive linear 
relationship with age at death was observed. 
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APPENDIX 1 
Results from main studies examining the AB prevalence in the general population
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Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Cauna et al 
1965 
USA 
[197] 
100 necroscopic cases. 
53 M and 47 F 
Analysis on lung smears 
41%. 
47% in M and 34% in F 
 
Elmes et al 
1965 
UK 
[198] 
200 M from routine 
necropsies as control 
population. 
100 cases in the age range 
50-59 years + 100 cases in 
the age range 60-69 years 
LM analysis on typical 
histologic lung sections 
20.5%. 
14% in the 50-59 years old series, 
27% in the 60-69 years old series 
Inclusion criterion for the control 
population: no diagnosis of lung 
carcinoma or mesothelioma 
Thomson 
1965 
1
st
 series) 
South Africa 
 
2
nd
 series) 
USA 
[199] 
1
st
 series) 
500 cases from 
consecutive necropsies, 
age > 15 years. 
 
2
nd
 series) 
500 cases from 
consecutive necropsies, 
age > 15 years 
LM analysis on basal lung 
smears 
1
st
 series) 
26.4%. 
30.4% in M and 20% in F. 
31.6% in the 55-64 years old subgroup 
(max). 
 
2
nd
 series) 
27.2%. 
31.6% in M and 20.4% in F. 
31.9% in the > 75 years old subgroup 
(max). 
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Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Anjilvel et al 
1966 
Canada 
[200] 
100 cases from random 
hospital necropsies. 
56 M and 44 F 
Age > 26 years 
LM analysis on scraping and 
squeezing lung smears 
48%. 
57% in M and 36% in F. 
30% in the 26-45 years old subgroup and 
50% in the > 45 years old subgroup 
4 cases with lung cancer 
Meurman 
1966 
Finland 
[201] 
264 cases from 
consecutive necropsies. 
148 M and 116 F. 
Age > 15 years 
LM analysis on iron-stained 
lung sections 
57.6%. 
60.1% in M and 54.3% in F. 
70% in urban residents and 49% in rural 
residents 
 
Hourihane et 
al 
1966 
UK 
[202] 
115 cases from hospital 
routine necropsies 
LM analysis on 30 µm-thick 
unstained lung sections 
24.3%  
Roitzsch 
1967 
Germany 
[203] 
250 cases Analysis on lung smears 43.2% 10 cases with pleural plaques 
Hefin Roberts 
1967 
UK 
[204] 
100 cases from 
consecutive hospital 
necropsies. 
62 M and 38 F. 
Age range 24-85 years 
LM analysis on basal lung 
smears 
23%. 
37% in M and 0% in F. 
47% of AB-positive cases < 5 AB 
13 cases with pleural plaques, 3 cases 
with lung cancer, 1 case with asbestosis 
and 4 cases with wide lung fibrosis 
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Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Ghezzi et al 
1967 
Italy 
[182] 
100 cases from random 
hospital necropsies. 
64 M and 36 F. 
Age range 25-83 years 
LM analysis on apical and 
basal lung smears 
51%. 
54% in M and 44% in F. 
14% in the < 50 years old subgroup and 
60-66% in the > 50 years old subgroup 
 
Polliack et al 
1968 
Israel 
[205] 
100 cases Analysis on lung smears 
26%. 
29.1% in M and 22.2% in F 
 
Ashcroft 
1968 
UK 
[206] 
311 cases from unselected 
necropsies. 
196 M and 115 F. 
Age > 15 years 
LM analysis on basal lung 
smears 
20.3%. 
25.5% in M and 11.3% in F. 
25% in urban residents and 3.5% in rural 
residents. 
No AB in M< 25 years and in F< 35 
years 
11 cases with lung cancer, 1 case with 
mesothelioma 
Bignon et al 
1969 
France 
[207] 
1
st
 series) 45 cases 
2
nd
 series) 103 cases 
LM analysis on sodium 
hypochlorite digested lung 
samples 
1
st
 series) 98% 
2
nd
 series) 99% 
 
Dicke et al 
1969 
USA 
[208] 
100 cases from 
consecutive necropsies. 
66 M and 34 F. 
Age range 16-88 years 
LM analysis on apical and 
basal lung smears 
18%. 
23% in M and 12% in F. 
No AB-positive cases in the  < 30 years 
old subgroup 
 
72 
 
Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Peacock et al 
1969 
Italy 
[180] 
109 cases from 
consecutive hospital 
necropsies. 
63 M and 46 F. 
Age range 23-90 years 
LM analysis on scraping lung 
smears 
0.9% 4 cases with lung cancer 
Xipell et al 
1969 
Australia 
[209] 
200 cases. 
138 M and 62 F 
Analysis on lung digested 
samples 
43.5%. 
44.2% in M and 41.9% in F 
1 case with pleural plaques 
Um 
1971 
UK 
[210] 
From consecutive hospital 
necropsies, age > 20 years: 
1
st 
series, from 1936) 127 
cases, 82 M and 45 F 
2
nd 
series, from 1946) 100 
cases, 61 M and 39 F 
3
rd
 series, from 1956) 100 
cases, 51 M and 48 F 
4
th
 series, from 1966) 100 
cases, 55 M and 45 F 
LM analysis on 5µm- and 
30µm-thick lung sections 
1
st
 series) 0% 
2
nd
 series) 3% 
3
rd
 series) 14% 
4
th
 series) 20% 
 
Nizze 
1971 
Germany 
[211] 
234 cases. 
121 M and 113 F 
Analysis on digested lung 
samples 
9%. 
11% in M and 8% in F 
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Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Plamenac et 
al 
1971 
Bosnia 
[212] 
100 cases. 
55 M and 45 F 
Analysis on lung smears 
38%. 
52.7% in M and 20% in F 
 
Rosen et al 
1972 
USA 
[213] 
86 cases from lung surgery 
and necropsies 
LM analysis on sodium 
hypochlorite digested and 
filtered lung samples 
93% 
1 case with mesothelioma and some cases 
with lung cancer 
Smith et al 
1972 
USA 
[214] 
100 cases from 
consecutive necropsies. 
66 M and 34 F. 
Age > 16 years 
LM analysis on sodium 
hypochlorite digested and 
filtered lung samples 
100% 6 cases with lung cancer 
Hagerstrand 
et al 
1973 
Sweden 
[215] 
97 cases from consecutive 
necropsies. 
59 M and 38 F. 
Age range 30-93 years 
Analysis on lung smears and 
on 30 μm-thick lung sections 
48.4%. 
54.2% in M and 39.4% in F 
29 cases with pleural plaques, 4 cases 
with lung cancer and 1 case with 
mesothelioma 
Bianchi et al 
1973 
Italy 
[216] 
50 cases from unselected 
hospital necropsies. 
24 M and 26 F. 
Age range 48-89 years 
LM analysis on centrifuged 
lung squeezing fluid 
70%. 
79% in M and 61% in F 
2 cases with lung cancer and 1 case with 
mesothelioma 
Fondimare et 
al 
1974 
France 
[217] 
52 unselected cases 
LM analysis on digested and 
filtered lung samples 
100%. 
92% of cases < 100 AB/4 g wet lung 
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Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Bianchi et al 
1974 
Italy 
[218] 
50 cases from unselected 
hospital necropsies. 
34 M and 16 F. 
Age range 28-83 years 
LM analysis on sodium 
hypochlorite digested lung 
samples 
96% Some cases with lung cancer 
Doniach et al 
1975 
UK 
[219] 
 
394 cases from 
consecutive hospital 
necropsies. 
216 M and 178 F. 
Age > 16 years. 
LM analysis on 30µm-thick 
unstained lung section 
37%. 
42% in M and 30% in F. 
60.9% in heavy manual workers and 
12.1% in clerical workers. 
45-53% in residents in industrial areas 
58 cases with lung carcinoma, 25 cases 
with pleural plaques. 
Exclusion criterion: diagnosis of 
asbestosis or mesothelioma 
Breedin et al 
1976 
USA 
[220] 
100 cases from 
consecutive necropsies. 
70 M and 30 F. 
Age > 16 years 
LM analysis on sodium 
hypochlorite digested and 
filtered lung samples 
93%. 
91% in urban residents and 95% in rural 
residents 
Exclusion criteria: 
lung neoplasm, known occupational 
exposure to asbestos 
Bhagavan et 
al 
1976 
USA 
[177] 
From consecutive 
necropsies: 
1
st
 series, from 1940-1949) 
61 cases 
2
nd
 series, from 1950-
1959) 
47 cases 
3
rd
 series, from 1970-
1972) 
145 cases 
LM analysis on sodium 
hypochlorite digested and 
filtered lung samples 
1
st
 series) 40.9% 
2
nd
 series) 61.7% 
3
rd
 series) 91.1% 
 
Gordon et al 
1976 
USA 
[221] 
28 cases from a hospital 
1928-1932 necroscopic 
archive. 
9 M and 19 F. 
Age range 17-76 years 
LM analysis on sodium 
hypochlorite digested and 
filtered lung samples 
39.3% 1 case with lung cancer 
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Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Bianchi et al 
1976 
Italy 
[222] 
50 cases from unselected 
necropsies. 
24 M and 26 F. 
Age range 23-90 years 
LM analysis on chemically 
digested lung samples 
88%  
Churg et al 
1977 
USA 
[53] 
252 cases from 234 
necropsies and 18 lung 
surgeries. 
152 M and 100 F. 
Age > 40 years 
LM analysis on sodium 
hypochlorite digested and 
filtered lung samples 
96% 
Women and white collar men with 
unimodal AB count < 50/g wet. Blue 
collar men with bimodal AB count with 
peaks < 50 g/wet and 100-499 g/wet 
54 cases with lung cancer 
 
Francis et al 
1977 
Scandinavia 
[223] 
198 cases from unselected 
necropsies 
 7% 66 cases with pleural plaques 
Roggli et al 
1980 
USA 
[224] 
52 cases as control 
population. 
Mean age 58.5 years 
LM analysis on sodium 
hypochlorite digested and 
filtered lung samples 
92% 
3 cases with lung cancer and 1 case with 
peritoneal mesothelioma 
Rubino et al 
1980 
Italy 
[225] 
218 M from unselected 
hospital necropsies 
LM analysis of lung smears 
31.8% in cases with no pleural plaques. 
49.2% in cases with < 100 cm
2 
pleural 
plaques. 87.5% in cases with > 100 cm
2 
pleural plaques 
67 cases with pleural plaques 
Bianchi et al 
1981 
Italy 
[226] 
100 cases from 
consecutive hospital 
necropsies 
LM analysis on chemically 
digested lung samples 
94% 
Pleural plaques in 72% of M 
and 33% of F 
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Year 
Place 
Population Methods AB prevalence Comment 
Steele et al 
1982 
UK + New 
Zealand 
[186] 
From lung surgery and 
unselected necropsies: 
1
st
 series, from UK) 319 
cases. 286 M and 33 F. 
Age range 16-92 years 
2
nd
 series from NZ) 248 
cases. 196 M and 52 F. 
Age range 15-92 years. 
3
rd
 series, from UK) 106 
cases.75 M and 31 F 
LM analysis in 30µm-thick 
unstained lung section for the 
1
st
 series. 
LM analysis on KOH digested 
and Perls stained lung samples 
for the 2
nd
 series and the 3
rd
 
series 
1
st
 series) 13% in M and 0% in F. 
2
nd
 series) 75%. 
78% in M and 63% in F. 
3
rd
 series) 80%. 
83% in M and 74% in F 
1
st
 series) 196 cases with lung cancer 
2
nd
 series) 167 cases with lung cancer 
3
rd
 series) 2 cases with mesothelioma and 
50 cases with lung cancer 
Andrion et al 
1982 
Italy 
[227] 
996 cases from unselected 
necropsies 
 12.4%  
Andrion et al 
1982 
Italy 
[228] 
Two series as control 
populations: 
1
st
 series) 26 cases from 
hospital necropsies. 
23 M and 3 F. 
Age range 42-80 years. 
2
nd
 series) 39 cases from 
surgeries. 
34 M and 5 F. 
Age range 35-72 years 
LM analysis on 30 μm-thick 
unstained lung sections 
1
st
 series) 26% in M and 0% in F. 
2
nd
 series) 23.5% in M and 20% in F 
Exclusion criterion for control 
populations: diagnosis of lung cancer, 
occupational exposure to asbestos 
Betta 
1982 
Italy 
[229] 
100 samples from 
consecutive hospital 
necropsies. 
71 M and 29 F. 
Mean age 56.8 years 
LM analysis on scraping lung 
smears 
52% 
57.7% in M and 35.7% in F. 
76% in urban residents and 45.9% in 
non-urban residents 
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Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Johansson et 
al 
1987 
Sweden 
[230] 
89 necroscopic cases as 
control population. 
Mean age 67 years 
LM analysis on 25 μm-thick 
unstained lung sections 
13.5% 
Exclusion criterion for the control 
population: known exposure to dust 
causing pneumoconiosis 
Haque et al 
1988 
USA 
[231] 
46 cases from paediatric 
necropsies. 
Age range 1-27 months 
LM analysis on sodium 
hypochlorite digested lung 
samples 
21.7%  
Wu et al 
1988 
Japan 
[232] 
92 necropsy cases 
Analysis on digested lung 
samples 
94.6% 60 cases with lung cancer 
Shishido et al 
1989 
Japan 
[178] 
From necropsies and lung 
surgery: 
1
st
 series) 1937-1941 
2
nd
 series) 1947-1951 
3
rd
 series) 1958-1963 
4
th
 series) 1970-1973 
5
th
 series)1980-1981 
LM analysis of sodium 
hypochlorite digested lung 
samples 
1
st
 series) 10% 
2
nd
 series) 18% 
3
rd
 series) 70% 
   4
th
 series) 74.4% 
5
th
 series) 81% 
 
Hiraoka et al 
1990 
Japan 
[233] 
369 cases from unselected 
hospital necropsies as 
control population. 
249 M and 120 F. 
Age > 35 years 
LM analysis on chemically 
digested and filtered lung 
samples 
80.2% of cases 0-19 AB/g wet. 
11.1% of cases 20-199 AB/g wet. 
7.1% of cases 200-1,999 AB/g wet. 
1.6% of cases ≥ 2,000 AB/g wet 
Exclusion criterion for the control 
population: diagnosis of lung cancer 
Langer et al 
1994 
USA 
[234] 
3000 cases from hospital 
necropsies. 
1971 M and 1029 F 
LM analysis on lung samples 
48.6% 
51.4% in M and 42.4% in F 
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Authors 
Year 
Place 
Population Methods AB prevalence Comment 
Arenas-
Huertero et al 
1994 
Mexico 
[179] 
180 cases from hospital 
necropsies in the 1975-
1988 period. 
104 M and 76 F 
LM analysis on sodium 
hypochlorite digested lung 
samples 
50% in 1975 
93% in 1977 
96% in 1981 
70% in 1982 
86% in 1983 
86% in 1988 
 
Monso et al 
1995 
Spain 
[235] 
1
st
 series) 
18 cases from an urban 
area. 
Mean age 62.2 years. 
2
nd
 series) 
16 cases from a rural area. 
Mean age 62.2 years 
 
1
st
 series) 50%. 
AB mean count 52.35/g dry. 
2
nd
 series) 12.5%. 
AB mean count 5.37/g dry 
3
rd
 series, 8 cases with lung carcinoma) 
AB prevalence 25%, mean AB count 
20.59/g dry 
King et al 
1996 
USA 
[236] 
16 cases selected as 
control population. 
Age range 36-83 
LM analysis on sodium 
hypochlorite digested lung 
samples 
12.5% 
Inclusion criterion for the control 
population: no history of occupational 
asbestos exposure 
Magnani et al 
1998 
Italy 
[181] 
31 cases from unselected 
hospital necropsies 
LM analysis on sodium 
hypochlorite digested lung 
samples 
80.7% 
Inclusion criterion: no known 
occupational exposure to asbestos 
Dodson et al 
1999 
USA 
[237] 
33 necropsy cases without 
known occupational 
exposure to asbestos. 
23 M and 10 F 
LM analysis on sodium 
hypochlorite digested and 
filtered lung samples 
21.2% 
Inclusion criterion: LM FB count ≤ 20/g 
wet 
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Year 
Place 
Population Methods AB prevalence Comment 
Liu et al 
2001 
China 
[238] 
107 cases from 
randomized hospital 
necropsies. 
44 M and 63 F 
PCLM analysis on chemically 
digested lung samples 
35.7% in M and 39.5% in F 
Inclusion criteria for the control 
population: no diagnosis of lung cancer, 
death due to acute myocardial infarction 
or to accidental death 
 
AB = Asbestos Bodies, FB = Ferruginous Bodies. 
F = Females, M = Males 
LM = Light Microscope, PCLM = Phase Contrast Light Microscope. 
KOH = potassium hydroxide. 
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APPENDIX 2 
Results from main studies examining the asbestos fibers burden in the general population
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Authors 
Year 
Place 
Population Methods 
Asbestos fibers 
count 
Comment 
Ashcroft 
1973 
UK 
[239] 
48 cases from routine necropsies 
as control population divided into 
2 subgroups. 
1
st
 subgroup) 18 cases with ≥ 1 
AB in the preliminary LM 
analysis. 
2
nd
 subgroup) 30 cases with no 
AB in the preliminary LM 
analysis 
Analysis on chemically 
digested lung samples 
1
st
 subgroup) 
range 0-7,760,000 ff/g dry. 
11% of cases having no detectable 
fibers 
2
nd
 subgroup) 
range 0-298,000 ff/g dry. 
57% of cases having no detectable 
fibers 
Inclusion criterion for the control 
population: no diagnosis of 
malignancies 
Whitwell et al 
1977 
UK 
[240] 
100 unselected necropsy cases as 
control population. 
72 M and 28 F. 
Age > 20 years 
PCLM analysis on 
chemically digested 
lung samples. Counting 
of both coated and 
uncoated asbestos fibers 
> 6 µm in length 
57% of the population < 10,000 ff/g 
dry, 
71% of the population < 20,000 ff/g 
dry, 
15% of the population > 50,000 ff/g 
dry 
Inclusion criteria for the control 
population: no diagnosis of lung 
cancer, mesothelioma or other 
“industrial disease”. 
55 cases with pleural plaques 
Churg et al 
1980 
USA 
[241] 
21 necropsy cases. 
11 M and 10 F. 
Age > 40 years, mean age 64 
years 
EM analysis on sodium 
hypochlorite digested 
lung samples 
Chrysotile range 12,000-680,000 
ff/g wet, mean chrysotile value 
130,000 ff/g wet. 
Amphibole range 1,300-75,000 ff/g 
wet, 
mean amphibole value 25,000 ff/g 
wet. 
Chrysotile and tremolite detected in 
100% of cases, commercial 
amphiboles detected in 52% of 
cases 
Inclusion criterion: preliminary AB 
count < 100/g wet. 
4 cases with lung cancer, 1 case with 
pleural plaques 
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Authors 
Year 
Place 
Population Methods 
Asbestos fibers 
count 
Comment 
Gylseth et al 
1981 
Norway 
[242] 
12 cases from consecutive 
necropsies as control population. 
8 M and 4 F. 
Age range 49-90 years 
SEM analysis on ashed 
lung samples 
Range 100,000-2,300,000 ff/g dry. 
75% of cases < 1,000,000 ff/g dry 
Controls died of cardiovascular 
disease 
Churg 
1982 
USA 
[99] 
25 cases as a control population. 
24 M and 1 F. 
Mean age 65 years 
EM analysis on sodium 
hypochlorite digested 
and filtered lung 
samples 
Mean value for all asbestos fibers 
99,000 ff/g wet. 
Mean values for chrysotile fibers 
68,000 ff/g wet. 
Mean values for non-commercial 
amphiboles 30,000 ff/g wet. 
Mean values for amosite fibers 
1,000 ff/g wet 
Inclusion criteria for the control 
population: no known occupational 
exposure to asbestos, absence of 
pleural plaques, AB count < 100/g wet 
lung 
Stovin et al 
1982 
UK 
[243] 
112 cases from consecutive 
necropsies. 
87 M and 25 F. 
Age range 45-74 years 
PCLM analysis on 
KOH digested lung 
samples. 
PCLM counting of all 
fibers > 8 µm in length 
31% of cases having no detectable 
fibers. 
Median value ≈ 5,000 ff/g dry 
10 cases with pleural plaques, 42 
cases with lung cancer and 4 cases 
with mesothelioma 
Mollo et al 
1983 
Italy 
[244] 
82 cases 
LM analysis on sodium 
hypochlorite digested 
lung samples. 
LM count of fibers > 10 
μm in length 
Maximum uncoated fibers count 
12,500 ff/g dry. 
Maximum coated fibers count 150 
AB/g dry 
82 cases without known asbestos 
exposure 
Mowè et al 
1984 
Norway 
[245] 
36 necropsy cases as control 
population. 
Mean age 67.9 years 
SEM analysis on ashed 
lung samples. 
SEM counting of all 
inorganic fibers 
Range 0-4,800,000 ff/g dry. 
Median value 300,000 ff/g dry. 
 
Inclusion criterion for the control 
population: death due to 
cardiovascular pathology 
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Authors 
Year 
Place 
Population Methods 
Asbestos fibers 
count 
Comment 
Mowè et al 
1985 
Norway 
[246] 
28 M from hospital necropsies as 
control population. 
Mean age 68.1 years 
SEM analysis on ashed 
lung samples 
Range 0-4,800,000 ff/g dry. 
25% of cases > 1,000,000 ff/g dry 
Exclusion criterion for the control 
population: diagnosis of lung cancer 
or chronic pulmonary disease 
Churg et al 
1986 
Canada 
[247] 
20 cases from unselected 
necropsies as control population 
EM analysis on sodium 
hypochlorite digested 
lung samples. 
EM counting of all 
fibers > 0.5 μm in 
length 
Chrysotile range 0-1,300,000 ff/g 
dry; 
chrysotile median value 200,000 
ff/g dry. 
Tremolite range 0-1,200,000 ff/g 
dry; 
tremolite median value 200,000 ff/g 
dry 
Inclusion criteria for the control 
population: no known occupational 
exposure to dust of any kind 
Tuommi et al 
1989 
Finland 
[248] 
15 cases from unselected 
necropsies as control population 
SEM analysis on ashed 
lung samples. 
Mineral fibers counting 
Range < 10,000-3,200,000 ff/g dry. 
20% of cases > 1,000,000 ff/g dry 
 
Albin et al 
1990 
Sweden 
[33] 
96 cases as control population 
TEM analysis on 
chemically digested 
lung samples 
Asbestos fibers median value 
29,000,000/g dry. 
Amphibole fibers median value 
150,000 ff/g dry 
 
Tuommi et al 
1991 
Finland 
[249] 
13 M from unselected necropsies 
as control population. 
Mean age 60 years 
SEM and TEM analysis 
on lung samples 
77% of cases < 1,000,000 ff/g dry. 
23% of cases ≥ 1,000,000. 
100% of cases < 10,000,000 ff/g 
dry 
 
Tuommi et al 
Finland 
1991 
[250] 
9 M from sudden death 
necropsies as control population. 
Age range 37-67 years 
SEM analysis on ashed 
lung samples 
Range < 100,000-600,000 ff/g dry  
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Year 
Place 
Population Methods 
Asbestos fibers 
count 
Comment 
Langer et al 
1994 
USA 
[251] 
126 cases from hospital 
necropsies 
TEM analysis on 
chemically digested 
lung samples. 
TEM chrysotile 
counting only 
Range for positive cases 1,800,000-
15,700,000 ff/g dry. 
Positive cases with TEM counting ≥ 
28 chrysotile fibrils 
Tossavainen et 
al 
1994 
Finland 
[252] 
10 M from unselected hospital 
necropsies as control population 
SEM analysis on ashed 
lung samples 
Range < 100,000-1,600,000 ff/g 
dry. 
Mean value 500,000 ff/g dry 
 
Karjalainen et 
al 
1994 
Finland 
[253] 
300 M from urban subjects 
necropsies. 
Age range 35-69 years 
SEM analysis on ashed 
lung samples. 
SEM counting for 
fibers ≥ 1 µm in lenght 
For the subgroup without pleural 
plaques: median value 160,000 ff/g 
dry; range 0-2,900,000 ff/g dry; 8% 
of such cases  ≥ 1,000,000 ff/g dry. 
For the subgroup with moderate 
pleural plaques: 
median value 400,000 ff/g dry; 
range 0-4,700,000 ff/g dry. 
For the subgroup with widespread 
pleural plaques: median value 
570,000 ff/g dry; range 0-
160,000,000 ff/g dry 
3 cases with lung carcinoma, 168 
cases with pleural plaques (80 cases 
with moderate pleural plaques and 88 
cases with widespread pleural 
plaques) 
Karjalainen et 
al 
1994 
Finland 
[254] 
300 M from sudden death 
necropsies. 
Age range 35-69 years 
SEM analysis on ashed 
and filtered lung 
samples. 
SEM counting of all 
fibers ≥ 1μm 
Range < 300,000-163,000,000 ff/g 
dry. 
18% of cases > 1,000,000 ff/g dry 
 
3 cases with lung cancer 
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Year 
Place 
Population Methods 
Asbestos fibers 
count 
Comment 
Karjalainen et 
al 
1994 
Finland 
[255] 
297 M from sudden death 
necropsies as control population. 
Age range 35-69 years, mean age 
52 years 
SEM analysis on ashed 
lung samples. 
SEM counting of all 
fibers > 1μm in length 
82.8% of cases < 1,000,000 ff/g 
dry. 2.3% of cases > 5,000,000 ff/g 
dry 
Exclusion criterion for the control 
population: diagnosis of lung 
carcinoma 
Dufresne et al 
1996 
Canada 
[256] 
49 cases from routine necropsies 
as control population divided into 
2 subgroups. 
1
st
 subgroup) 23 cases born 
before 1940. 
2
nd
 subgroup) 26 cases born after 
1940 
TEM analysis on 
sodium hypochlorite 
digested and filtered 
lung samples 
1
st
 subgroup) 
Mean value for fibers < 5 μm in 
length 700,000 ff/g dry. 
Mean value for fibers 5-10 μm in 
length 134,000 ff/g dry. 
Mean value for fibers > 10 μm in 
length 74,000 ff/g dry 
2
nd
 subgroup) 
Mean value for fibers < 5 μm in 
length 162,000 ff/g dry. 
Mean value for fibers 5-10 μm in 
length 65,000 ff/g dry. 
Mean value for fibers > 10 μm in 
length 42,000 ff/g dry 
 
Magnani et al 
1998 
Italy 
[181] 
31 cases from unselected hospital 
necropsies 
 
TEM analysis on 
sodium hypochlorite 
digested and filtered 
lung samples. 
TEM counting of all 
fibers 
No asbestos fibers detected in 
54.8% of cases. 
Mean value for asbestos fibers 
24,000 ff/g dry. 
Mean value for chrysotile fibers 
5,000 ff/g dry. 
Mean value for crocidolite fibers 
10,000 ff/g dry. 
Mean value for tremolite fibers 
6,000 ff/g dry 
Inclusion criterion: no known 
occupational exposure to asbestos 
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Year 
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Population Methods 
Asbestos fibers 
count 
Comment 
Dodson et al 
1999 
USA 
[237] 
 
Dodson et al 
2000 
USA 
[257] 
33 necropsy cases. 
23 M and 10 F. 
Age range 12-73 years 
TEM analysis on 
sodium hypochlorite 
digested and filtered 
lung samples 
Range 0-290,000 ff/g dry. 
Mean value for the 0-290,000 ff/g 
dry interval: 84,000/g dry. 
Mean value for the 32,000-290,000 
ff/g dry interval: 120,000/g dry. 
Chrysotile = 35% of all detected 
asbestos fibers. 
Chrysotile detected in 42.4% of 
cases   
Inclusion criteria: no known 
occupational exposure to asbestos, 
lung histology negative for asbestos-
related diseases, preliminary LM FB 
count ≤ 20/g wet 
 
Tossavainen et 
al 
2000 
Russia 
[258] 
23 cases from necropsies as 
control population. 
17 M and 6 F. 
Age range 1 month-81 years, 
mean age 49 years 
SEM analysis on ashed 
and filtered  lung 
samples. 
SEM counting of all 
fibers > 1μm in length 
Chrysotile range 100,000-
14,600,000 ff/g dry; chrysotile 
mean value 2,630,000 ff/g dry. 
Tremolite + anthophyllite range 
< 100,000-700,000 ff/g dry; mean 
tremolite + anthophyllite value 
180,000 ff/g dry 
Inclusion criterion for the control 
population: no known occupational 
asbestos exposure 
Liu et al 
2001 
China 
[238] 
107 cases from unselected 
hospital necropsies as control 
population. 
44 M and 63 F 
PCLM analysis on 
chemically digested 
lung samples 
Median values: 
0 ff/g dry in the 10-40 years old 
subgroup, 
32,000 ff/g dry in the 40-70 years 
old subgroup, 
52,000 ff/g dry in the > 70 years old 
subgroup. 
Median value for M 32.500/g dry. 
Median value for F 37,000/g dry. 
18.8% of the control population 
with values > 100,000 ff/g dry 
Inclusion criteria for the control 
population: no diagnosis of lung 
cancer, death due to acute myocardial 
infarction or to exogenous accident 
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Authors 
Year 
Place 
Population Methods 
Asbestos fibers 
count 
Comment 
McDonald et al 
2001 
UK 
[259] 
57 cases from necropsies as 
control population. 
Age range 36-52 years 
TEM analysis on KOH 
digested lung samples 
For chrysotile: 
33.4% of cases < DL, 36.8% of 
cases 100,000-900,000 ff/g dry, 
28% of cases 1,000,000-10,000,000 
ff/g dry, 1.8% of cases > 
10,000,000 ff/g dry. 
For amphiboles: 
49.1% of cases < DL, 42.1% of 
cases 100,000-900,000 ff/g dry, 
7.0% of cases 1,000,000-
10,000,000 ff/g dry, 1.8% of cases 
> 10,000,000 ff/g dry 
Inclusion criterion for the control 
population: sudden or accidental death 
Roggli et al 
2010 
USA 
[127] 
20 cases from necropsies SEM analysis 
Range: 4,000-169,000 ff/g dry. 
Median value 31,000 ff/g dry 
 
Inclusion criteria: normal lungs at 
autopsy, preliminary AB count within 
the general population range 
 
AB = Asbestos Body, FB = Ferruginous Body. 
F = Females, M = Males.  
DL = Detection Limit. 
LM = Light Microscope, PCLM = Phase Contrast Light Microscope, EM = Electron Microscope, SEM = Scanning Electron Microscope, 
TEM = Transmission Electron Microscope. 
KOH = potassium hydroxide. 
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